<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<meta name="keywords" content="AIDS,AIDS.ogg,AIDS,1981,1987,1994 expanded World Health Organization AIDS case definition,2003,2005,2006,ACET,AIDS Museum" />
<link rel="shortcut icon"  />
<link rel="search" type="application/opensearchdescription+xml"  />
<link rel="copyright"  />
		<title>AIDS - Wikipedia, the free encyclopedia</title>
		<style type="text/css" media="screen,projection">/*<![CDATA[*/ @import "/skins-1.5/monobook/main.css?9"; /*]]>*/</style>
		<link rel="stylesheet" type="text/css" media="print"  />
		<!--[if lt IE 5.5000]><style type="text/css">@import "/skins-1.5/monobook/IE50Fixes.css";</style><![endif]-->
		<!--[if IE 5.5000]><style type="text/css">@import "/skins-1.5/monobook/IE55Fixes.css";</style><![endif]-->
		<!--[if IE 6]><style type="text/css">@import "/skins-1.5/monobook/IE60Fixes.css";</style><![endif]-->
		<!--[if IE 7]><style type="text/css">@import "/skins-1.5/monobook/IE70Fixes.css?1";</style><![endif]-->
		<!--[if lt IE 7]><script type="text/javascript" src="/skins-1.5/common/IEFixes.js"></script>
		<meta http-equiv="imagetoolbar" content="no" /><![endif]-->
		
		<script type= "text/javascript">
			var skin = "monobook";
			var stylepath = "/skins-1.5";

			var wgArticlePath = "/wiki/$1";
			var wgScriptPath = "/w";
			var wgServer = "http://en.wikipedia.org";
                        
			var wgCanonicalNamespace = "";
			var wgNamespaceNumber = 0;
			var wgPageName = "AIDS";
			var wgTitle = "AIDS";
			var wgArticleId = 5069516;
			var wgIsArticle = true;
                        
			var wgUserName = null;
			var wgUserLanguage = "en";
			var wgContentLanguage = "en";
		</script>
		                
		<script type="text/javascript" src="/skins-1.5/common/wikibits.js?1"><!-- wikibits js --></script>
		<script type="text/javascript" src="/w/index.php?title=-&amp;action=raw&amp;gen=js"><!-- site js --></script>
		<style type="text/css">/*<![CDATA[*/
@import "/w/index.php?title=MediaWiki:Common.css&usemsgcache=yes&action=raw&ctype=text/css&smaxage=2678400";
@import "/w/index.php?title=MediaWiki:Monobook.css&usemsgcache=yes&action=raw&ctype=text/css&smaxage=2678400";
@import "/w/index.php?title=-&action=raw&gen=css&maxage=2678400";
/*]]>*/</style>
		<!-- Head Scripts -->
		<script type="text/javascript" src="/skins-1.5/common/ajax.js"></script>
	</head>
<body  class="mediawiki ns-0 ltr">
	<div id="globalWrapper">
		<div id="column-content">
	<div id="content">
		<a name="top" id="top"></a>
		<div id="siteNotice"><div style="text-align:right; font-size:80%">Your <b><a  class="extiw" title="wikimedia:Fundraising">continued donations</a></b> keep Wikipedia running!&nbsp;&nbsp;&nbsp;&nbsp;</div>
</div>		<h1 class="firstHeading">AIDS</h1>
		<div id="bodyContent">
			<h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
			<div id="contentSub"></div>
									<div id="jump-to-nav">Jump to: <a >navigation</a>, <a >search</a></div>			<!-- start content -->
			<table class="infobox" style="width: 20em; font-size: 95%; text-align: left;">
<caption style="background: lightgrey; font-size: 95%;"><b>Acquired Immunodeficiency Syndrome (AIDS)</b></caption>
<tr>
<th colspan="2" style="text-align: center; font-size: smaller;">
<div class="center">
<div class="floatnone"><span><a  class="image" title=""><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/9/9e/Red_ribbon.png/120px-Red_ribbon.png" alt="" width="120" height="179" longdesc="/wiki/Image:Red_ribbon.png" /></a></span></div>
</div>
</th>
</tr>
<tr style="line-height: 1;">
<td colspan="2" style="text-align:center;"><small>The <a href="/wiki/Red_ribbon.html" title="Red ribbon">Red ribbon</a> is a symbol for solidarity with HIV-positive people and those living with AIDS.</small></td>
</tr>
<tr>
<th><a href="/wiki/List_of_ICD-10_codes.html" title="List of ICD-10 codes">ICD-10</a></th>
<td><a href="/wiki/ICD-10_Chapter_B.html" title="ICD-10 Chapter B">B</a><a  class="external text" title="http://www3.who.int/icd/currentversion/gb20.htm#b24">24.</a></td>
</tr>
<tr>
<th><a href="/wiki/List_of_ICD-9_codes.html" title="List of ICD-9 codes">ICD-9</a></th>
<td><a  class="external text" title="http://icd9.chrisendres.com/index.php?action=search&amp;srchtext=042">042</a></td>
</tr>
<tr>
<th><a href="/wiki/Diseases_Database.html" title="Diseases Database">DiseasesDB</a></th>
<td><a  class="external text" title="http://www.diseasesdatabase.com/ddb5938.htm">5938</a></td>
</tr>
<tr>
<th><a href="/wiki/MedlinePlus.html" title="MedlinePlus">MedlinePlus</a></th>
<td><a  class="external text" title="http://www.nlm.nih.gov/medlineplus/ency/article/000594.htm">000594</a></td>
</tr>
<tr>
<th><a href="/wiki/EMedicine.html" title="EMedicine">eMedicine</a></th>
<td><a  class="external text" title="http://www.emedicine.com/emerg/topic253.htm">emerg/253</a></td>
</tr>
</table>
<p><b>Acquired Immunodeficiency Syndrome</b> or <b>Acquired Immune Deficiency Syndrome</b> (<b>AIDS</b> or <b>Aids</b>) is a <a href="/wiki/Syndrome.html" title="Syndrome">collection of symptoms and infections</a> in <a href="/wiki/Human.html" title="Human">humans</a> resulting from the specific damage to the <a href="/wiki/Immune_system.html" title="Immune system">immune system</a> caused by the <a href="/wiki/HIV.html" title="HIV">human immunodeficiency virus</a> (HIV).<sup id="_ref-Marx_0" class="reference"><a  title="">[1]</a></sup> The late stage of the condition leaves individuals prone to <a href="/wiki/Opportunistic_infection.html" title="Opportunistic infection">opportunistic infections</a> and <a href="/wiki/Tumor.html" title="Tumor">tumors</a>. Although treatments for AIDS and HIV exist to slow the <a href="/wiki/Virus.html" title="Virus">virus</a>'s progression, there is no known cure. HIV is <a href="/wiki/Transmission_%28medicine%29.html" title="Transmission (medicine)">transmitted</a> through direct contact of a <a href="/wiki/Mucous_membrane.html" title="Mucous membrane">mucous membrane</a> or the bloodstream with a <a href="/wiki/Bodily_fluid.html" title="Bodily fluid">bodily fluid</a> containing HIV, such as <a href="/wiki/Blood.html" title="Blood">blood</a>, <a href="/wiki/Semen.html" title="Semen">semen</a>, <a href="/wiki/Vaginal_fluid.html" title="Vaginal fluid">vaginal fluid</a>, <a href="/wiki/Preseminal_fluid.html" title="Preseminal fluid">preseminal fluid</a>, and <a href="/wiki/Breast_milk.html" title="Breast milk">breast milk</a>.<sup id="_ref-CDCtransmission_0" class="reference"><a  title="">[2]</a></sup><sup id="_ref-sfaf_0" class="reference"><a  title="">[3]</a></sup> This transmission can come in the form of <a href="/wiki/Anal_sex.html" title="Anal sex">anal</a>, <a href="/wiki/Vaginal_sex.html" title="Vaginal sex">vaginal</a> or <a href="/wiki/Oral_sex.html" title="Oral sex">oral</a> <a href="/wiki/Sexual_intercourse.html" title="Sexual intercourse">sex</a>, <a href="/wiki/Blood_transfusion.html" title="Blood transfusion">blood transfusion</a>, contaminated <a href="/wiki/Needle.html" title="Needle">needles</a>, exchange between <a href="/wiki/Mother.html" title="Mother">mother</a> and <a href="/wiki/Baby.html" title="Baby">baby</a> during <a href="/wiki/Pregnancy.html" title="Pregnancy">pregnancy</a>, <a href="/wiki/Childbirth.html" title="Childbirth">childbirth</a>, or <a href="/wiki/Breastfeeding.html" title="Breastfeeding">breastfeeding</a>, or other exposure to one of the above bodily fluids.</p>
<p>Most researchers believe that HIV originated in <a href="/wiki/Sub-Saharan_Africa.html" title="Sub-Saharan Africa">sub-Saharan Africa</a> during the <a href="/wiki/Twentieth_century.html" title="Twentieth century">twentieth century</a>;<sup id="_ref-Gao_0" class="reference"><a  title="">[4]</a></sup> it is now a <a href="/wiki/Pandemic.html" title="Pandemic">pandemic</a>, with an estimated 38.6 <a href="/wiki/Million.html" title="Million">million</a> people now living with the disease worldwide.<sup id="_ref-UNAIDS2006_0" class="reference"><a  title="">[5]</a></sup> As of January 2006, the <a href="/wiki/Joint_United_Nations_Programme_on_HIV/AIDS.html" title="Joint United Nations Programme on HIV/AIDS">Joint United Nations Programme on HIV/AIDS</a> (UNAIDS) and the <a href="/wiki/World_Health_Organization.html" title="World Health Organization">World Health Organization</a> (WHO) estimate that AIDS has killed more than 25 million people since it was first recognized on <a href="/wiki/June_5.html" title="June 5">June 5</a>, <a href="/wiki/1981.html" title="1981">1981</a>, making it one of the most destructive <a href="/wiki/Epidemic.html" title="Epidemic">epidemics</a> in <a href="/wiki/Recorded_history.html" title="Recorded history">recorded history</a>. In 2005 alone, AIDS claimed an estimated 2.4 - 3.3 million lives, of which more than 570,000 were children.<sup id="_ref-UNAIDS2006_1" class="reference"><a  title="">[5]</a></sup> A third of these deaths are occurring in sub-Saharan <a href="/wiki/Africa.html" title="Africa">Africa</a>, retarding <a href="/wiki/Economic_growth.html" title="Economic growth">economic growth</a> and destroying <a href="/wiki/Human_capital.html" title="Human capital">human capital</a>. <a href="/wiki/Antiretroviral_drug.html" title="Antiretroviral drug">Antiretroviral</a> <a href="/wiki/Therapy.html" title="Therapy">treatment</a> reduces both the <a href="/wiki/Mortality.html" title="Mortality">mortality</a> and the <a href="/wiki/Morbidity.html" title="Morbidity">morbidity</a> of HIV infection, but routine access to antiretroviral <a href="/wiki/Medication.html" title="Medication">medication</a> is not available in all countries.<sup id="_ref-Palella_0" class="reference"><a  title="">[6]</a></sup> HIV/AIDS <a href="/wiki/Social_stigma.html" title="Social stigma">stigma</a> is more severe than that associated with other life-threatening conditions and extends beyond the disease itself to providers and even <a href="/wiki/Volunteer.html" title="Volunteer">volunteers</a> involved with the care of people living with HIV.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a ><span class="tocnumber">1</span> <span class="toctext">Infection by HIV</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">2</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2"><a ><span class="tocnumber">2.1</span> <span class="toctext">WHO disease staging system for HIV infection and disease</span></a></li>
<li class="toclevel-2"><a ><span class="tocnumber">2.2</span> <span class="toctext">CDC classification system for HIV infection</span></a></li>
<li class="toclevel-2"><a ><span class="tocnumber">2.3</span> <span class="toctext">HIV test</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a ><span class="tocnumber">3</span> <span class="toctext">Symptoms and complications</span></a>
<ul>
<li class="toclevel-2"><a ><span class="tocnumber">3.1</span> <span class="toctext">Major pulmonary illnesses</span></a></li>
<li class="toclevel-2"><a ><span class="tocnumber">3.2</span> <span class="toctext">Major gastro-intestinal illnesses</span></a></li>
<li class="toclevel-2"><a ><span class="tocnumber">3.3</span> <span class="toctext">Major neurological illnesses</span></a></li>
<li class="toclevel-2"><a ><span class="tocnumber">3.4</span> <span class="toctext">Major HIV-associated malignancies</span></a></li>
<li class="toclevel-2"><a ><span class="tocnumber">3.5</span> <span class="toctext">Other opportunistic infections</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a ><span class="tocnumber">4</span> <span class="toctext">Transmission and prevention</span></a>
<ul>
<li class="toclevel-2"><a ><span class="tocnumber">4.1</span> <span class="toctext">Sexual contact</span></a></li>
<li class="toclevel-2"><a ><span class="tocnumber">4.2</span> <span class="toctext">Exposure to infected body fluids</span></a></li>
<li class="toclevel-2"><a ><span class="tocnumber">4.3</span> <span class="toctext">Mother-to-child transmission (MTCT)</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a ><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">7</span> <span class="toctext">Economic impact</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">8</span> <span class="toctext">Stigma</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">9</span> <span class="toctext">Origin of HIV</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">10</span> <span class="toctext">Alternative hypotheses</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">11</span> <span class="toctext">Common misconceptions</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">12</span> <span class="toctext">Notes and references</span></a></li>
<li class="toclevel-1"><a ><span class="tocnumber">13</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script></p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Infection by HIV">edit</a>]</div>
<p><a name="Infection_by_HIV" id="Infection_by_HIV"></a></p>
<h2>Infection by HIV</h2>
<div class="boilerplate seealso">
<dl>
<dd><i>For more details on this topic, see <a href="/wiki/HIV.html" title="HIV">HIV</a>.</i></dd>
</dl>
</div>
<div class="thumb tright">
<div style="width:302px;"><a  class="internal" title="Scanning electron micrograph of HIV-1 budding from cultured lymphocyte."><img src="http://upload.wikimedia.org/wikipedia/en/thumb/2/2f/HIV-budding.jpg/300px-HIV-budding.jpg" alt="Scanning electron micrograph of HIV-1 budding from cultured lymphocyte." width="300" height="199" longdesc="/wiki/Image:HIV-budding.jpg" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a  class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="Enlarge" /></a></div>
<a href="/wiki/Scanning_electron_microscope.html" title="Scanning electron microscope">Scanning electron micrograph</a> of HIV-1 budding from cultured <a href="/wiki/Lymphocyte.html" title="Lymphocyte">lymphocyte</a>.</div>
</div>
</div>
<p>AIDS is the most severe manifestation of <a href="/wiki/Infection.html" title="Infection">infection</a> with HIV. HIV is a <a href="/wiki/Retrovirus.html" title="Retrovirus">retrovirus</a> that primarily infects vital components of the human <a href="/wiki/Immune_system.html" title="Immune system">immune system</a> such as <a href="/wiki/T_helper_cell.html" title="T helper cell">CD4<sup>+</sup> T cells</a> (a subset of <a href="/wiki/T_cell.html" title="T cell">T cells</a>), <a href="/wiki/Macrophage.html" title="Macrophage">macrophages</a> and <a href="/wiki/Dendritic_cell.html" title="Dendritic cell">dendritic cells</a>. It directly and indirectly destroys CD4<sup>+</sup> T cells. CD4<sup>+</sup> T cells are required for the proper functioning of the immune system. When HIV kills CD4<sup>+</sup> T cells so that there are fewer than 200 CD4<sup>+</sup> T cells per <a href="/wiki/Microliter.html" title="Microliter">microliter</a> (µL) of <a href="/wiki/Blood.html" title="Blood">blood</a>, <a href="/wiki/Cellular_immunity.html" title="Cellular immunity">cellular immunity</a> is lost, leading to the condition known as AIDS. <a  class="new" title="Acute (medicine)">Acute</a> HIV infection progresses over time to clinical <a href="/wiki/Latent.html" title="Latent">latent</a> HIV infection and then to early <a href="/wiki/Symptomatic.html" title="Symptomatic">symptomatic</a> HIV infection and later, to AIDS, which is identified on the basis of the amount of CD4<sup>+</sup> T cells in the blood and the presence of certain infections.</p>
<p>In the absence of <a href="/wiki/Antiretroviral_drugs.html" title="Antiretroviral drugs">antiretroviral therapy</a>, the <a href="/wiki/Median.html" title="Median">median</a> <a href="/wiki/HIV_Disease_Progression_Rates.html" title="HIV Disease Progression Rates">time of progression from HIV infection to AIDS</a> is nine to ten <a href="/wiki/Year.html" title="Year">years</a>, and the median survival time after developing AIDS is only 9.2 <a href="/wiki/Month.html" title="Month">months</a>.<sup id="_ref-Morgan2_0" class="reference"><a  title="">[7]</a></sup> However, the rate of clinical disease progression varies widely between individuals, from two <a href="/wiki/Week.html" title="Week">weeks</a> up to 20 years. Many factors affect the rate of progression. These include factors that influence the body's ability to defend against HIV such as the infected person's general immune function.<sup id="_ref-Clerici_0" class="reference"><a  title="">[8]</a></sup><sup id="_ref-Morgan_0" class="reference"><a  title="">[9]</a></sup> Older people have weaker immune systems, and therefore have a greater risk of rapid disease progression than younger people. Poor access to <a href="/wiki/Health_care.html" title="Health care">health care</a> and the existence of coexisting infections such as <a href="/wiki/Tuberculosis.html" title="Tuberculosis">tuberculosis</a> also may predispose people to faster disease progression.<sup id="_ref-Morgan2_1" class="reference"><a  title="">[7]</a></sup><sup id="_ref-Gendelman_0" class="reference"><a  title="">[10]</a></sup><sup id="_ref-Bentwich_0" class="reference"><a  title="">[11]</a></sup> The infected person's <a href="/wiki/Genetics.html" title="Genetics">genetic inheritance</a> plays an important role and some people are <a  class="new" title="Resistant">resistant</a> to certain strains of HIV.<sup id="_ref-Tang_0" class="reference"><a  title="">[12]</a></sup> An example of this is people with the <a href="/wiki/CCR5-%CE%9432.html" title="CCR5-Δ32">CCR5-Δ32</a> mutation are resistant to infection with certain <a href="/wiki/Strain_%28biology%29.html" title="Strain (biology)">strains</a> of HIV. HIV is genetically variable and exists as different strains, which cause different rates of clinical disease progression.<sup id="_ref-Quinones_0" class="reference"><a  title="">[13]</a></sup><sup id="_ref-Campbell_0" class="reference"><a  title="">[14]</a></sup><sup id="_ref-Kaleebu_0" class="reference"><a  title="">[15]</a></sup> The use of highly active antiretroviral therapy prolongs both the median time of progression to AIDS and the median survival time.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Diagnosis">edit</a>]</div>
<p><a name="Diagnosis" id="Diagnosis"></a></p>
<h2>Diagnosis</h2>
<p>Since <a href="/wiki/June_5.html" title="June 5">June 5</a>, <a href="/wiki/1981.html" title="1981">1981</a>, many definitions have been developed for <a href="/wiki/Epidemiology.html" title="Epidemiology">epidemiological</a> surveillance such as the <a href="/wiki/Bangui_definition.html" title="Bangui definition">Bangui definition</a> and the <a href="/wiki/1994_expanded_World_Health_Organization_AIDS_case_definition.html" title="1994 expanded World Health Organization AIDS case definition">1994 expanded World Health Organization AIDS case definition</a>. However, clinical staging of patients was not an intended use for these systems as they are neither sensitive, nor specific. In developing countries, the <a href="/wiki/World_Health_Organization.html" title="World Health Organization">World Health Organization</a> staging system for HIV infection and disease, using clinical and laboratory data, is used and in developed countries, the <a href="/wiki/Centers_for_Disease_Control_and_Prevention.html" title="Centers for Disease Control and Prevention">Centers for Disease Control</a> (CDC) Classification System is used.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: WHO disease staging system for HIV infection and disease">edit</a>]</div>
<p><a name="WHO_disease_staging_system_for_HIV_infection_and_disease" id="WHO_disease_staging_system_for_HIV_infection_and_disease"></a></p>
<h3>WHO disease staging system for HIV infection and disease</h3>
<dl>
<dd>
<div class="noprint"><i>Main article: <a href="/wiki/WHO_Disease_Staging_System_for_HIV_Infection_and_Disease.html" title="WHO Disease Staging System for HIV Infection and Disease">WHO Disease Staging System for HIV Infection and Disease</a></i></div>
</dd>
</dl>
<p>In 1990, the <a href="/wiki/World_Health_Organization.html" title="World Health Organization">World Health Organization</a> (WHO) grouped these infections and conditions together by introducing a staging system for patients infected with HIV-1.<sup id="_ref-WHO_0" class="reference"><a  title="">[16]</a></sup> An update took place in September 2005. Most of these conditions are <a href="/wiki/Opportunistic_infections.html" title="Opportunistic infections">opportunistic infections</a> that are easily treatable in healthy people.</p>
<dl>
<dd><i>Stage I:</i> HIV disease is asymptomatic and not categorized as AIDS</dd>
<dd><i>Stage II:</i> includes minor <a href="/wiki/Mucous_membrane.html" title="Mucous membrane">mucocutaneous</a> manifestations and recurrent <a href="/wiki/Upper_respiratory_tract.html" title="Upper respiratory tract">upper respiratory tract</a> infections</dd>
<dd><i>Stage III:</i> includes unexplained <a href="/wiki/Chronic.html" title="Chronic">chronic</a> <a href="/wiki/Diarrhea.html" title="Diarrhea">diarrhea</a> for longer than a month, severe bacterial infections and <a href="/wiki/Pulmonary.html" title="Pulmonary">pulmonary</a> tuberculosis</dd>
<dd><i>Stage IV:</i> includes <a href="/wiki/Toxoplasmosis.html" title="Toxoplasmosis">toxoplasmosis</a> of the <a href="/wiki/Brain.html" title="Brain">brain</a>, <a href="/wiki/Candidiasis.html" title="Candidiasis">candidiasis</a> of the <a href="/wiki/Esophagus.html" title="Esophagus">esophagus</a>, <a href="/wiki/Trachea.html" title="Trachea">trachea</a>, <a href="/wiki/Bronchi.html" title="Bronchi">bronchi</a> or <a href="/wiki/Lung.html" title="Lung">lungs</a> and <a href="/wiki/Kaposi%27s_sarcoma.html" title="Kaposi's sarcoma">Kaposi's sarcoma</a>; these diseases are indicators of AIDS.</dd>
</dl>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: CDC classification system for HIV infection">edit</a>]</div>
<p><a name="CDC_classification_system_for_HIV_infection" id="CDC_classification_system_for_HIV_infection"></a></p>
<h3>CDC classification system for HIV infection</h3>
<dl>
<dd>
<div class="noprint"><i>Main article: <a href="/wiki/CDC_Classification_System_for_HIV_Infection.html" title="CDC Classification System for HIV Infection">CDC Classification System for HIV Infection</a></i></div>
</dd>
</dl>
<p>The <a href="/wiki/Centers_for_Disease_Control_and_Prevention.html" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> (CDC) originally classified AIDS as GRID which stood for <a href="/wiki/Gay_Related_Immune_Disease.html" title="Gay Related Immune Disease">Gay Related Immune Disease</a>. However, after determining that AIDS is not isolated to <a href="/wiki/Homosexual.html" title="Homosexual">homosexual</a> people the name was changed to the neutral AIDS. In 1993, the CDC expanded their definition of AIDS to include all HIV positive people with a CD4<sup>+</sup> T cell count below 200 per µL of blood or 14% of all <a href="/wiki/Lymphocyte.html" title="Lymphocyte">lymphocytes</a>.<sup id="_ref-MMWR_0" class="reference"><a  title="">[17]</a></sup> The majority of new AIDS cases in <a href="/wiki/Developed_country.html" title="Developed country">developed countries</a> use either this definition or the pre-1993 CDC definition. The AIDS diagnosis still stands even if, after treatment, the CD4<sup>+</sup> T cell count rises to above 200 per µL of blood or other AIDS-defining illnesses are cured.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: HIV test">edit</a>]</div>
<p><a name="HIV_test" id="HIV_test"></a></p>
<h3>HIV test</h3>
<dl>
<dd>
<div class="noprint"><i>Main article: <a href="/wiki/HIV_test.html" title="HIV test">HIV test</a></i></div>
</dd>
</dl>
<p>Many people are unaware that they are infected with HIV. For example, less than 1% of the sexually active urban population in Africa has been tested and this proportion is even lower in rural populations. Furthermore, only 0.5% of pregnant women attending urban health facilities are counselled, tested or receive their test results. Again, this proportion is even lower in rural health facilities.<sup id="_ref-Kumaranayake_0" class="reference"><a  title="">[18]</a></sup> Therefore, <a href="/wiki/Donor_blood.html" title="Donor blood">donor blood</a> and blood products used in medicine and medical research are screened for HIV. Typical HIV tests, including the HIV <a href="/wiki/Enzyme.html" title="Enzyme">enzyme</a> <a href="/wiki/Immunoassay.html" title="Immunoassay">immunoassay</a> and the <a href="/wiki/Western_blot.html" title="Western blot">Western blot</a> assay, detect HIV <a href="/wiki/Antibody.html" title="Antibody">antibodies</a> in <a href="/wiki/Blood_plasma.html" title="Blood plasma">serum</a>, <a href="/wiki/Plasma.html" title="Plasma">plasma</a>, oral fluid, dried blood spot or <a href="/wiki/Urine.html" title="Urine">urine</a> of patients. However, the <a href="/wiki/Window_period.html" title="Window period">window period</a> (the time between initial infection and the development of detectable antibodies against the infection) can vary. This is why it can take 6-12 months to <a href="/wiki/Seroconversion.html" title="Seroconversion">seroconvert</a> and test positive. Commercially available tests to detect other HIV antigens, HIV-<a href="/wiki/RNA.html" title="RNA">RNA</a>, and HIV-<a href="/wiki/DNA.html" title="DNA">DNA</a> in order to detect HIV infection prior to the development of detectable antibodies are available. For the diagnosis of HIV infection these <a href="/wiki/Assay.html" title="Assay">assays</a> are not specifically approved, but are nonetheless routinely used in <a href="/wiki/Developed_countries.html" title="Developed countries">developed countries</a>.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Symptoms and complications">edit</a>]</div>
<p><a name="Symptoms_and_complications" id="Symptoms_and_complications"></a></p>
<h2>Symptoms and complications</h2>
<div class="thumb tright">
<div style="width:402px;"><a  class="internal" title="A generalized graph of the relationship between HIV copies (viral load) and CD4 counts over the average course of untreated HIV infection; any particular individual's disease course may vary considerably. &#160;CD4+ T Lymphocyte count (cells/mm3) &#160;HIV RNA copies per mL of plasma "><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/a/a4/Hiv-timecourse.png/400px-Hiv-timecourse.png" alt="A generalized graph of the relationship between HIV copies (viral load) and CD4 counts over the average course of untreated HIV infection; any particular individual's disease course may vary considerably. &#160;CD4+ T Lymphocyte count (cells/mm3) &#160;HIV RNA copies per mL of plasma " width="400" height="224" longdesc="/wiki/Image:Hiv-timecourse.png" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a  class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="Enlarge" /></a></div>
A generalized graph of the relationship between HIV copies (viral load) and CD4 counts over the average course of untreated HIV infection; any particular individual's disease course may vary considerably.
<table style="border-collapse:collapse">
<tr>
<td style="padding:0">
<div style="border-width:0; border-top:2px dotted #000; border-top:blue solid 2px; width:1em; position:relative; margin-bottom:-9px; top:.6em">&#160;</div>
</td>
<td style="padding:0 0 0 .2em">CD4<sup>+</sup> T Lymphocyte count (cells/mm<sup>3</sup>)</td>
</tr>
</table>
<table style="border-collapse:collapse">
<tr>
<td style="padding:0">
<div style="border-width:0; border-top:2px dotted #000; border-top:red solid 2px; width:1em; position:relative; margin-bottom:-9px; top:.6em">&#160;</div>
</td>
<td style="padding:0 0 0 .2em">HIV RNA copies per mL of plasma</td>
</tr>
</table>
</div>
</div>
</div>
<p>The symptoms of AIDS are primarily the result of conditions that do not normally develop in individuals with healthy <a href="/wiki/Immune_system.html" title="Immune system">immune systems</a>. Most of these conditions are infections caused by <a href="/wiki/Bacteria.html" title="Bacteria">bacteria</a>, <a href="/wiki/Virus.html" title="Virus">viruses</a>, <a href="/wiki/Fungus.html" title="Fungus">fungi</a> and <a href="/wiki/Parasite.html" title="Parasite">parasites</a> that are normally controlled by the elements of the immune system that HIV damages. <a href="/wiki/Opportunistic_infection.html" title="Opportunistic infection">Opportunistic infections</a> are common in people with AIDS.<sup id="_ref-Holmes_0" class="reference"><a  title="">[19]</a></sup> HIV affects nearly every <a href="/wiki/Organ_system.html" title="Organ system">organ system</a>. People with AIDS also have an increased risk of developing various cancers such as <a href="/wiki/Kaposi_sarcoma.html" title="Kaposi sarcoma">Kaposi sarcoma</a>, <a href="/wiki/Cervical_cancer.html" title="Cervical cancer">cervical cancer</a> and cancers of the immune system known as <a href="/wiki/Lymphoma.html" title="Lymphoma">lymphomas</a>.</p>
<p>Additionally, people with AIDS often have systemic symptoms of infection like <a href="/wiki/Fever.html" title="Fever">fevers</a>, <a href="/wiki/Sweat.html" title="Sweat">sweats</a> (particularly at night), swollen glands, chills, weakness, and <a href="/wiki/Weight_loss.html" title="Weight loss">weight loss</a>.<sup id="_ref-Guss_0" class="reference"><a  title="">[20]</a></sup><sup id="_ref-Guss2_0" class="reference"><a  title="">[21]</a></sup> After the diagnosis of AIDS is made, the current average survival time with antiretroviral therapy is estimated to be now more than 5 years,<sup id="_ref-Schneider_0" class="reference"><a  title="">[22]</a></sup> but because new treatments continue to be developed and because HIV continues to <a href="/wiki/Evolve.html" title="Evolve">evolve</a> resistance to treatments, estimates of survival time are likely to continue to change. Without antiretroviral therapy, death normally occurs within a year.<sup id="_ref-Morgan2_2" class="reference"><a  title="">[7]</a></sup> Most patients die from opportunistic infections or <a  class="new" title="Malignancies">malignancies</a> associated with the progressive failure of the immune system.<sup id="_ref-Lawn_0" class="reference"><a  title="">[23]</a></sup></p>
<p>The rate of clinical disease progression varies widely between individuals and has been shown to be affected by many factors such as host susceptibility and immune function<sup id="_ref-Clerici_1" class="reference"><a  title="">[8]</a></sup><sup id="_ref-Morgan_1" class="reference"><a  title="">[9]</a></sup><sup id="_ref-Tang_1" class="reference"><a  title="">[12]</a></sup> health care and co-infections,<sup id="_ref-Morgan2_3" class="reference"><a  title="">[7]</a></sup><sup id="_ref-Lawn_1" class="reference"><a  title="">[23]</a></sup> as well as factors relating to the viral strain.<sup id="_ref-Campbell_1" class="reference"><a  title="">[14]</a></sup><sup id="_ref-Campbell2_0" class="reference"><a  title="">[24]</a></sup><sup id="_ref-Senkaali_0" class="reference"><a  title="">[25]</a></sup> The specific opportunistic infections that AIDS patients develop depend in part on the prevalence of these infections in the geographic area in which the patient lives.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Major pulmonary illnesses">edit</a>]</div>
<p><a name="Major_pulmonary_illnesses" id="Major_pulmonary_illnesses"></a></p>
<h3>Major pulmonary illnesses</h3>
<div class="thumb tright">
<div style="width:152px;"><a  class="internal" title="X-ray of Pneumocystis jiroveci pneumonia There is increased white (opacity) in the lower lungs on both sides, characteristic of Pneumocystis pneumonia"><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/7/74/PCPxray.jpg/150px-PCPxray.jpg" alt="X-ray of Pneumocystis jiroveci pneumonia There is increased white (opacity) in the lower lungs on both sides, characteristic of Pneumocystis pneumonia" width="150" height="210" longdesc="/wiki/Image:PCPxray.jpg" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a  class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="Enlarge" /></a></div>
<b>X-ray of Pneumocystis jiroveci pneumonia</b> There is increased white (opacity) in the lower lungs on both sides, characteristic of <i>Pneumocystis</i> pneumonia</div>
</div>
</div>
<ul>
<li><a href="/wiki/Pneumocystis_jiroveci_pneumonia.html" title="Pneumocystis jiroveci pneumonia"><i>Pneumocystis jiroveci</i> pneumonia</a> (originally known as <i>Pneumocystis carinii</i> pneumonia, often-abbreviated PCP) is relatively rare in healthy, <a href="/wiki/Immunocompetent.html" title="Immunocompetent">immunocompetent</a> people, but common among HIV-infected individuals. Before the advent of effective diagnosis, treatment and routine <a href="/wiki/Prophylaxis.html" title="Prophylaxis">prophylaxis</a> in Western countries, it was a common immediate cause of death. In developing countries, it is still one of the first indications of AIDS in untested individuals, although it does not generally occur unless the CD4 count is less than 200 per µL.<sup id="_ref-Feldman_0" class="reference"><a  title="">[26]</a></sup></li>
<li><a href="/wiki/Tuberculosis.html" title="Tuberculosis">Tuberculosis</a> (TB) is unique among infections associated with HIV because it is transmissible to immunocompetent people via the respiratory route, is easily treatable once identified, may occur in early-stage HIV disease, and is preventable with drug therapy. However, <a href="/wiki/Multi-drug_resistance.html" title="Multi-drug resistance">multi-drug resistance</a> is a potentially serious problem. Even though its incidence has declined because of the use of directly observed therapy and other improved practices in Western countries, this is not the case in developing countries where HIV is most prevalent. In early-stage HIV infection (CD4 count &gt;300 cells per µL), TB typically presents as a pulmonary disease. In advanced HIV infection, TB often presents atypically with extrapulmonary (systemic) disease a common feature. Symptoms are usually constitutional and are not localized to one particular site, often affecting <a href="/wiki/Bone_marrow.html" title="Bone marrow">bone marrow</a>, <a href="/wiki/Bone.html" title="Bone">bone</a>, urinary and <a href="/wiki/Gastrointestinal_tract.html" title="Gastrointestinal tract">gastrointestinal tracts</a>, <a href="/wiki/Liver.html" title="Liver">liver</a>, regional <a href="/wiki/Lymph_node.html" title="Lymph node">lymph nodes</a>, and the <a href="/wiki/Central_nervous_system.html" title="Central nervous system">central nervous system</a>.<sup id="_ref-Decker_0" class="reference"><a  title="">[27]</a></sup> Alternatively, symptoms may relate more to the site of extrapulmonary involvement.</li>
</ul>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Major gastro-intestinal illnesses">edit</a>]</div>
<p><a name="Major_gastro-intestinal_illnesses" id="Major_gastro-intestinal_illnesses"></a></p>
<h3>Major gastro-intestinal illnesses</h3>
<ul>
<li><a href="/wiki/Esophagitis.html" title="Esophagitis">Esophagitis</a> is an inflammation of the lining of the lower end of the <a href="/wiki/Esophagus.html" title="Esophagus">esophagus</a> (gullet or swallowing tube leading to the <a href="/wiki/Stomach.html" title="Stomach">stomach</a>). In HIV infected individuals, this is normally due to fungal (<a href="/wiki/Candidiasis.html" title="Candidiasis">candidiasis</a>) or viral (<a href="/wiki/Herpes_simplex_virus.html" title="Herpes simplex virus">herpes simplex-1</a> or <a href="/wiki/Cytomegalovirus.html" title="Cytomegalovirus">cytomegalovirus</a>) infections. In rare cases, it could be due to <a href="/wiki/Mycobacteria.html" title="Mycobacteria">mycobacteria</a>.<sup id="_ref-Zaidi_0" class="reference"><a  title="">[28]</a></sup></li>
<li>Unexplained chronic <a href="/wiki/Diarrhea.html" title="Diarrhea">diarrhea</a> in HIV infection is due to many possible causes, including common bacterial (<i><a href="/wiki/Salmonella.html" title="Salmonella">Salmonella</a></i>, <i><a href="/wiki/Shigella.html" title="Shigella">Shigella</a></i>, <i><a href="/wiki/Listeria.html" title="Listeria">Listeria</a></i>, <i><a href="/wiki/Campylobacter.html" title="Campylobacter">Campylobacter</a></i>, or <i><a href="/wiki/Escherichia_coli.html" title="Escherichia coli">Escherichia coli</a></i>) and parasitic infections, and uncommon opportunistic infections such as <a href="/wiki/Cryptosporidiosis.html" title="Cryptosporidiosis">cryptosporidiosis</a>, <a href="/wiki/Microsporidiosis.html" title="Microsporidiosis">microsporidiosis</a>, <i><a href="/wiki/Mycobacterium_avium.html" title="Mycobacterium avium">Mycobacterium avium</a></i> complex (MAC) and <a href="/wiki/Cytomegalovirus.html" title="Cytomegalovirus">cytomegalovirus</a> (CMV) <a href="/wiki/Colitis.html" title="Colitis">colitis</a>. In some cases, diarrhea may be a side effect of several drugs used to treat HIV, or it may simply accompany HIV infection, particularly during primary HIV infection. It may also be a side effect of <a href="/wiki/Antibiotic.html" title="Antibiotic">antibiotics</a> used to treat bacterial causes of diarrhea (common for <i><a href="/wiki/Clostridium_difficile.html" title="Clostridium difficile">Clostridium difficile</a></i>). In the later stages of HIV infection, diarrhea is thought to be a reflection of changes in the way the <a href="/wiki/Intestinal_tract.html" title="Intestinal tract">intestinal tract</a> absorbs nutrients, and may be an important component of HIV-related <a href="/wiki/Wasting.html" title="Wasting">wasting</a>.<sup id="_ref-Guerrant_0" class="reference"><a  title="">[29]</a></sup></li>
</ul>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Major neurological illnesses">edit</a>]</div>
<p><a name="Major_neurological_illnesses" id="Major_neurological_illnesses"></a></p>
<h3>Major neurological illnesses</h3>
<ul>
<li><a href="/wiki/Toxoplasmosis.html" title="Toxoplasmosis">Toxoplasmosis</a> is a disease caused by the single-celled <a href="/wiki/Parasite.html" title="Parasite">parasite</a> called <i>Toxoplasma gondii</i>; it usually infects the brain causing toxoplasma <a href="/wiki/Encephalitis.html" title="Encephalitis">encephalitis</a> but it can infect and cause disease in the <a href="/wiki/Eye.html" title="Eye">eyes</a> and lungs.<sup id="_ref-Luft_0" class="reference"><a  title="">[30]</a></sup></li>
<li><a href="/wiki/Progressive_multifocal_leukoencephalopathy.html" title="Progressive multifocal leukoencephalopathy">Progressive multifocal leukoencephalopathy</a> (PML) is a <a href="/wiki/Demyelinating_disease.html" title="Demyelinating disease">demyelinating disease</a>, in which the gradual destruction of the <a href="/wiki/Myelin.html" title="Myelin">myelin</a> sheath covering the <a href="/wiki/Axons.html" title="Axons">axons</a> of nerve cells impairs the transmission of nerve impulses. It is caused by a virus called <a href="/wiki/JC_virus.html" title="JC virus">JC virus</a> which occurs in 70% of the population in <a href="/wiki/Latent.html" title="Latent">latent</a> form, causing disease only when the immune system has been severely weakened, as is the case for AIDS patients. It progresses rapidly, usually causing death within months of diagnosis.<sup id="_ref-Sadler_0" class="reference"><a  title="">[31]</a></sup></li>
<li><a href="/wiki/AIDS_dementia_complex.html" title="AIDS dementia complex">AIDS dementia complex</a> (ADC) is a metabolic <a href="/wiki/Encephalopathy.html" title="Encephalopathy">encephalopathy</a> induced by HIV infection and fuelled by immune activation of HIV infected brain <a href="/wiki/Macrophage.html" title="Macrophage">macrophages</a> and <a href="/wiki/Microglia.html" title="Microglia">microglia</a> which secrete <a href="/wiki/Neurotoxin.html" title="Neurotoxin">neurotoxins</a> of both host and viral origin.<sup id="_ref-Gray_0" class="reference"><a  title="">[32]</a></sup> Specific neurological impairments are manifested by cognitive, behavioral, and motor abnormalities that occur after years of HIV infection and is associated with low CD4<sup>+</sup> T cell levels and high plasma viral loads. Prevalence is 10-20% in Western countries<sup id="_ref-Grant_0" class="reference"><a  title="">[33]</a></sup> but only 1-2% of HIV infections in <a href="/wiki/India.html" title="India">India</a>.<sup id="_ref-Satischandra_0" class="reference"><a  title="">[34]</a></sup><sup id="_ref-Wadia_0" class="reference"><a  title="">[35]</a></sup> This difference is possibly due to the HIV subtype in <a href="/wiki/India.html" title="India">India</a>.</li>
<li>Cryptococcal meningitis is an infection of the <a href="/wiki/Meninges.html" title="Meninges">meninx</a> (the membrane covering the brain and <a href="/wiki/Spinal_cord.html" title="Spinal cord">spinal cord</a>) by the fungus <i><a href="/wiki/Cryptococcus.html" title="Cryptococcus">Cryptococcus</a> neoformans</i>. It can cause fevers, <a href="/wiki/Headache.html" title="Headache">headache</a>, <a href="/wiki/Fatigue.html" title="Fatigue">fatigue</a>, <a href="/wiki/Nausea.html" title="Nausea">nausea</a>, and <a href="/wiki/Vomiting.html" title="Vomiting">vomiting</a>. Patients may also develop <a href="/wiki/Seizure.html" title="Seizure">seizures</a> and confusion; left untreated, it can be lethal.</li>
</ul>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Major HIV-associated malignancies">edit</a>]</div>
<p><a name="Major_HIV-associated_malignancies" id="Major_HIV-associated_malignancies"></a></p>
<h3>Major HIV-associated malignancies</h3>
<p>Patients with HIV infection have substantially increased incidence of several malignant <a href="/wiki/Cancer.html" title="Cancer">cancers</a>. This is primarily due to co-infection with an <a href="/wiki/Oncogene.html" title="Oncogene">oncogenic</a> <a href="/wiki/DNA_virus.html" title="DNA virus">DNA virus</a>, especially <a href="/wiki/Epstein-Barr_virus.html" title="Epstein-Barr virus">Epstein-Barr virus</a> (EBV), Kaposi's sarcoma-associated herpesvirus (KSHV), and human <a href="/wiki/Papillomavirus.html" title="Papillomavirus">papillomavirus</a> (HPV).<sup id="_ref-Boshoff_0" class="reference"><a  title="">[36]</a></sup><sup id="_ref-Yarchoan_0" class="reference"><a  title="">[37]</a></sup> The following confer a diagnosis of AIDS when they occur in an HIV-infected person.</p>
<ul>
<li>Kaposi's sarcoma (KS) is the most common tumor in HIV-infected patients. The appearance of this tumor in young homosexual men in 1981 was one of the first signals of the AIDS epidemic. Caused by a <a  class="new" title="Gammaherpes">gammaherpes</a> virus called <a href="/wiki/Kaposi%27s_sarcoma-associated_herpes_virus.html" title="Kaposi's sarcoma-associated herpes virus">Kaposi's sarcoma-associated herpes virus</a> (KSHV), it often appears as purplish <a href="/wiki/Nodule.html" title="Nodule">nodules</a> on the skin, but can affect other organs, especially the <a href="/wiki/Mouth.html" title="Mouth">mouth</a>, gastrointestinal tract, and lungs.</li>
<li>High-grade <a href="/wiki/B_cell.html" title="B cell">B cell</a> <a href="/wiki/Lymphoma.html" title="Lymphoma">lymphomas</a> such as <a href="/wiki/Burkitt%27s_lymphoma.html" title="Burkitt's lymphoma">Burkitt's lymphoma</a>, Burkitt's-like lymphoma, diffuse large B-cell lymphoma (DLBCL), and <a href="/wiki/Primary_central_nervous_system_lymphoma.html" title="Primary central nervous system lymphoma">primary central nervous system lymphoma</a> present more often in HIV-infected patients. These particular cancers often foreshadow a poor prognosis. In some cases these lymphomas are AIDS-defining. <a href="/wiki/Epstein-Barr_virus.html" title="Epstein-Barr virus">Epstein-Barr virus</a> (EBV) or KSHV cause many of these lymphomas.</li>
<li><a href="/wiki/Cervical_cancer.html" title="Cervical cancer">Cervical cancer</a> in HIV-infected women is considered AIDS-defining. It is caused by <a href="/wiki/Human_papillomavirus.html" title="Human papillomavirus">human papillomavirus</a> (HPV).</li>
</ul>
<p>In addition to the AIDS-defining tumors listed above, HIV-infected patients are at increased risk of certain other tumors, such as <a href="/wiki/Hodgkin%27s_disease.html" title="Hodgkin's disease">Hodgkin's disease</a> and <a href="/wiki/Anal_carcinoma.html" title="Anal carcinoma">anal</a> and <a href="/wiki/Rectal_carcinoma.html" title="Rectal carcinoma">rectal carcinomas</a>. However, the incidence of many common tumors, such as <a href="/wiki/Breast_cancer.html" title="Breast cancer">breast cancer</a> or <a href="/wiki/Colon_cancer.html" title="Colon cancer">colon cancer</a>, does not increase in HIV-infected patients. In areas where <a href="/wiki/HAART.html" title="HAART">HAART</a> is extensively used to treat AIDS, the incidence of many AIDS-related malignancies has decreased, but at the same time malignant cancers overall have become the most common cause of death of HIV-infected patients.<sup id="_ref-Bonnet_0" class="reference"><a  title="">[38]</a></sup></p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Other opportunistic infections">edit</a>]</div>
<p><a name="Other_opportunistic_infections" id="Other_opportunistic_infections"></a></p>
<h3>Other opportunistic infections</h3>
<p>AIDS patients often develop opportunistic infections that present with non-specific symptoms, especially <a href="/wiki/Low-grade_fever.html" title="Low-grade fever">low-grade fevers</a> and weight loss. These include infection with <i><a href="/wiki/Mycobacterium_avium.html" title="Mycobacterium avium">Mycobacterium avium</a>-intracellulare</i> and <a href="/wiki/Cytomegalovirus.html" title="Cytomegalovirus">cytomegalovirus</a> (CMV). CMV can cause colitis, as described above, and <a href="/wiki/Cytomegalovirus_retinitis.html" title="Cytomegalovirus retinitis">CMV retinitis</a> can cause <a href="/wiki/Blindness.html" title="Blindness">blindness</a>. <a href="/wiki/Penicilliosis.html" title="Penicilliosis">Penicilliosis</a> due to <i><a href="/wiki/Penicillium_marneffei.html" title="Penicillium marneffei">Penicillium marneffei</a></i> is now the third most common opportunistic infection (after extrapulmonary tuberculosis and <a href="/wiki/Cryptococcosis.html" title="Cryptococcosis">cryptococcosis</a>) in HIV-positive individuals within the endemic area of <a href="/wiki/Southeast_Asia.html" title="Southeast Asia">Southeast Asia</a>.<sup id="_ref-Skoulidis_0" class="reference"><a  title="">[39]</a></sup></p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Transmission and prevention">edit</a>]</div>
<p><a name="Transmission_and_prevention" id="Transmission_and_prevention"></a></p>
<h2>Transmission and prevention</h2>
<table class="prettytable" style="float:right; font-size:85%; margin-left:15px;">
<caption>Estimated per act risk for acquisition of HIV by exposure route<sup id="_ref-MMWR3_0" class="reference"><a  title="">[40]</a></sup></caption>
<tr bgcolor="#EFEFEF">
<th style="width: 100px">Exposure Route</th>
<th style="width: 150px">Estimated infections per 10,000 exposures to an infected source</th>
</tr>
<tr>
<th style="text-align:left">Blood Transfusion</th>
<td>9,000<sup id="_ref-Donegan_0" class="reference"><a  title="">[41]</a></sup></td>
</tr>
<tr>
<th style="text-align:left">Childbirth</th>
<td>2,500<sup id="_ref-Coovadia_0" class="reference"><a  title="">[42]</a></sup></td>
</tr>
<tr>
<th style="text-align:left">Needle-sharing injection drug use</th>
<td>67<sup id="_ref-Kaplan_0" class="reference"><a  title="">[43]</a></sup></td>
</tr>
<tr>
<th style="text-align:left">Receptive anal intercourse<sup>*</sup></th>
<td>50<sup id="_ref-ESG_0" class="reference"><a  title="">[44]</a></sup><sup id="_ref-Varghese_0" class="reference"><a  title="">[45]</a></sup></td>
</tr>
<tr>
<th style="text-align:left">Percutaneous needle stick</th>
<td>30<sup id="_ref-Bell_0" class="reference"><a  title="">[46]</a></sup></td>
</tr>
<tr>
<th style="text-align:left">Receptive penile-vaginal intercourse<sup>*</sup></th>
<td>10<sup id="_ref-ESG_1" class="reference"><a  title="">[44]</a></sup><sup id="_ref-Varghese_1" class="reference"><a  title="">[45]</a></sup><sup id="_ref-Leynaert_0" class="reference"><a  title="">[47]</a></sup></td>
</tr>
<tr>
<th style="text-align:left">Insertive anal intercourse<sup>*</sup></th>
<td>6.5<sup id="_ref-ESG_2" class="reference"><a  title="">[44]</a></sup><sup id="_ref-Varghese_2" class="reference"><a  title="">[45]</a></sup></td>
</tr>
<tr>
<th style="text-align:left">Insertive penile-vaginal intercourse<sup>*</sup></th>
<td>5<sup id="_ref-ESG_3" class="reference"><a  title="">[44]</a></sup><sup id="_ref-Varghese_3" class="reference"><a  title="">[45]</a></sup></td>
</tr>
<tr>
<th style="text-align:left">Receptive oral intercourse<sup>*</sup></th>
<td>1<sup id="_ref-Varghese_4" class="reference"><a  title="">[45]</a></sup><sup>§</sup></td>
</tr>
<tr>
<th style="text-align:left">Insertive oral intercourse<sup>*</sup></th>
<td>0.5<sup id="_ref-Varghese_5" class="reference"><a  title="">[45]</a></sup><sup>§</sup></td>
</tr>
<tr bgcolor="#EFEFEF">
<th colspan="5"><sup>*</sup> assuming no condom use<br />
<sup>§</sup> Source refers to oral intercourse performed on a man</th>
</tr>
</table>
<p>The three main transmission routes of HIV are <a href="/wiki/Sexual_contact.html" title="Sexual contact">sexual contact</a>, exposure to infected body fluids or tissues and from mother to <a href="/wiki/Fetus.html" title="Fetus">fetus</a> or child during <a href="/wiki/Perinatal.html" title="Perinatal">perinatal</a> period. It is possible to find HIV in the <a href="/wiki/Saliva.html" title="Saliva">saliva</a>, <a href="/wiki/Tears.html" title="Tears">tears</a>, and <a href="/wiki/Urine.html" title="Urine">urine</a> of infected individuals, but due to the low concentration of virus in these biological liquids, the risk is negligible.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Sexual contact">edit</a>]</div>
<p><a name="Sexual_contact" id="Sexual_contact"></a></p>
<h3>Sexual contact</h3>
<p>The majority of HIV infections are acquired through <a href="/wiki/Unprotected_sex.html" title="Unprotected sex">unprotected sexual</a> relations between partners, one of whom has HIV. Sexual transmission occurs with the contact between sexual secretions of one partner with the rectal, genital or oral <a href="/wiki/Mucous_membrane.html" title="Mucous membrane">mucous membranes</a> of another. Unprotected receptive sexual acts are riskier than unprotected insertive sexual acts, with the risk for transmitting HIV from an infected partner to an uninfected partner through unprotected insertive anal intercourse greater than the risk for transmission through vaginal intercourse or oral sex. Oral sex is not without its risks as HIV is transmissible through both insertive and receptive oral sex.<sup id="_ref-Rothenberg_0" class="reference"><a  title="">[48]</a></sup> The risk of HIV transmission from exposure to <a href="/wiki/Saliva.html" title="Saliva">saliva</a> is considerably smaller than the risk from exposure to <a href="/wiki/Semen.html" title="Semen">semen</a>; contrary to popular belief, one would have to swallow gallons of saliva from a carrier to run a significant risk of becoming infected.<sup id="_ref-Vincenzi_0" class="reference"><a  title="">[49]</a></sup></p>
<p><a href="/wiki/Sexually_transmitted_infection.html" title="Sexually transmitted infection">Sexually transmitted infections</a> (STI) increase the risk of HIV transmission and infection because they cause the disruption of the normal <a href="/wiki/Epithelial.html" title="Epithelial">epithelial</a> barrier by genital <a href="/wiki/Ulceration.html" title="Ulceration">ulceration</a> and/or microulceration; and by accumulation of pools of HIV-susceptible or HIV-infected cells (<a href="/wiki/Lymphocyte.html" title="Lymphocyte">lymphocytes</a> and <a href="/wiki/Macrophage.html" title="Macrophage">macrophages</a>) in semen and vaginal secretions. Epidemiological studies from sub-Saharan Africa, <a href="/wiki/Europe.html" title="Europe">Europe</a> and <a href="/wiki/North_America.html" title="North America">North America</a> have suggested that there is approximately a four times greater risk of becoming infected with HIV in the presence of a genital ulcer such as those caused by <a href="/wiki/Syphilis.html" title="Syphilis">syphilis</a> and/or <a href="/wiki/Chancroid.html" title="Chancroid">chancroid</a>. There is also a significant though lesser increased risk in the presence of STDs such as <a href="/wiki/Gonorrhea.html" title="Gonorrhea">gonorrhea</a>, <a href="/wiki/Chlamydia.html" title="Chlamydia">Chlamydial</a> infection and <a href="/wiki/Trichomoniasis.html" title="Trichomoniasis">trichomoniasis</a> which cause local accumulations of lymphocytes and macrophages.<sup id="_ref-Laga_0" class="reference"><a  title="">[50]</a></sup></p>
<p>Transmission of HIV depends on the infectiousness of the <a href="/wiki/Index_case.html" title="Index case">index case</a> and the susceptibility of the uninfected partner. Infectivity seems to vary during the course of illness and is not constant between individuals. An undetectable plasma viral load does not necessarily indicate a low viral load in the seminal liquid or genital secretions. Each 10-fold increment of blood plasma HIV RNA is associated with an 81% increased rate of HIV transmission.<sup id="_ref-Laga_1" class="reference"><a  title="">[50]</a></sup><sup id="_ref-Tovanabutra_0" class="reference"><a  title="">[51]</a></sup> Women are more susceptible to HIV-1 infection due to hormonal changes, vaginal microbial ecology and physiology, and a higher prevalence of sexually transmitted diseases.<sup id="_ref-Sagar_0" class="reference"><a  title="">[52]</a></sup><sup id="_ref-Lavreys_0" class="reference"><a  title="">[53]</a></sup> People who are infected with HIV can still be infected by other, more <a href="/wiki/Virulent.html" title="Virulent">virulent</a> strains.</p>
<p>During a sexual act, only male or female <a href="/wiki/Condom.html" title="Condom">condoms</a> can reduce the chances of infection with HIV and other STDs and the chances of becoming <a href="/wiki/Pregnant.html" title="Pregnant">pregnant</a>. The best evidence to date indicates that typical condom use reduces the risk of <a href="/wiki/Heterosexual.html" title="Heterosexual">heterosexual</a> HIV transmission by approximately 80% over the long-term, though the benefit is likely to be higher if condoms are used correctly on every occasion.<sup id="_ref-Cayley_0" class="reference"><a  title="">[54]</a></sup> The effective use of condoms and screening of blood transfusion in North America, Western and Central Europe is credited with contributing to the low rates of AIDS in these regions.</p>
<p>Promoting condom use, however, has often proved controversial and difficult. Many religious groups, most noticeably the <a href="/wiki/Catholic_Church.html" title="Catholic Church">Catholic Church</a>, have opposed the use of condoms on religious grounds, and have sometimes seen condom promotion as an affront to the promotion of <a href="/wiki/Marriage.html" title="Marriage">marriage</a>, <a href="/wiki/Monogamy.html" title="Monogamy">monogamy</a> and sexual morality. This attitude is found among some health care providers and policy makers in sub-Saharan African nations, where HIV and AIDS prevalence is extremely high.<sup id="_ref-HRW_0" class="reference"><a  title="">[55]</a></sup> They also believe that the distribution and promotion of condoms is tantamount to promoting sex amongst the youth and sending the wrong message to uninfected individuals. However, no evidence has been produced that promotion of condom use increases sexual <a href="/wiki/Promiscuity.html" title="Promiscuity">promiscuity</a>. <a href="/wiki/Pope_Benedict_XVI.html" title="Pope Benedict XVI">Pope Benedict XVI</a> commissioned a report on whether it might be acceptable for Catholics to use condoms to protect life inside a marriage when one partner is infected with HIV, or is sick with AIDS.<sup id="_ref-Fisher_0" class="reference"><a  title="">[56]</a></sup> Defenders of the Catholic Church's role in AIDS and general STD prevention state that, while they may be against the use of contraception, they are strong advocates of <a href="/wiki/Abstinence.html" title="Abstinence">abstinence</a> outside marriage.<sup id="_ref-catechism_0" class="reference"><a  title="">[57]</a></sup> Conversely, some religious groups have argued that preventing HIV infection is a moral task in itself and that condoms are therefore acceptable or even praiseworthy from a religious point of view.</p>
<div class="thumb tright">
<div style="width:182px;"><a  class="internal" title="Condoms in many colors"><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/46/Condoms_by_Morrhigan.jpg/180px-Condoms_by_Morrhigan.jpg" alt="Condoms in many colors" width="180" height="135" longdesc="/wiki/Image:Condoms_by_Morrhigan.jpg" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a  class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="Enlarge" /></a></div>
Condoms in many colors</div>
</div>
</div>
<p>The male <a href="/wiki/Latex.html" title="Latex">latex</a> condom, if used correctly without oil-based lubricants, is the single most efficient available technology to reduce the sexual transmission of HIV and other sexually transmitted infections. Manufacturers recommend that oil-based lubricants such as <a href="/wiki/Petroleum_jelly.html" title="Petroleum jelly">petroleum jelly</a>, <a href="/wiki/Butter.html" title="Butter">butter</a>, and <a href="/wiki/Lard.html" title="Lard">lard</a> not be used with latex condoms as they weaken the <a href="/wiki/Latex.html" title="Latex">latex</a>, making the condoms <a href="/wiki/Porous.html" title="Porous">porous</a>. If necessary, manufacturers recommend using <a href="/wiki/Water.html" title="Water">water</a>-based lubricants. Oil-based lubricants can however be used with <a href="/wiki/Polyurethane.html" title="Polyurethane">polyurethane</a> condoms.<sup id="_ref-Durex_0" class="reference"><a  title="">[58]</a></sup> Latex degrades over time, making them porous, which is why condoms have <a href="/wiki/Expiration_date.html" title="Expiration date">expiration dates</a>. In Europe and the United States, condoms have to conform to European (EC 600) or American (D3492) standards to be considered protective against HIV transmission.</p>
<p><a href="/wiki/Condom#Female_condoms.html" title="Condom">The female condom</a> is an alternative to the male condom and is made from <a href="/wiki/Polyurethane.html" title="Polyurethane">polyurethane</a>, which allows it to be used in the presence of oil-based lubricants. They are larger than male condoms and have a stiffened ring-shaped opening, and are designed to be inserted into the vagina. The female condom contains an inner ring, which keeps the condom in place inside the vagina – inserting the female condom requires squeezing this ring.</p>
<p>With consistent and correct use of condoms, there is a very low risk of HIV infection. Studies on couples where one partner is infected show that with consistent condom use, HIV infection rates for the uninfected partner are below 1% per year.<sup id="_ref-WHOCondoms_0" class="reference"><a  title="">[59]</a></sup></p>
<p>The United States government and health organizations both endorse the <i>ABC Approach</i> to lower the risk of acquiring AIDS during sex:</p>
<dl>
<dd><b>A</b>bstinence or delay of sexual activity, especially for youth,</dd>
<dd><b>B</b>eing faithful, especially for those in committed relationships,</dd>
<dd><b>C</b>ondom use, for those who engage in risky behavior.</dd>
</dl>
<p>This approach has been very successful in <a href="/wiki/Uganda.html" title="Uganda">Uganda</a>, where HIV prevalence has decreased from 15% to 5%. However, more has been done than implementing the ABC Approach as <a href="/wiki/Edward_Green.html" title="Edward Green">Edward Green</a>, a <a href="/wiki/Harvard.html" title="Harvard">Harvard</a> medical <a href="/wiki/Anthropologist.html" title="Anthropologist">anthropologist</a> put it, "<i>Uganda has pioneered approaches towards reducing stigma, bringing discussion of sexual behavior out into the open, involving HIV-infected people in public education, persuading individuals and couples to be tested and counseled, improving the status of women, involving religious organizations, enlisting traditional healers, and much more.</i>" Other programs and initiatives promote condom use more heavily. Condom use is an integral part of the <i>CNN Approach</i>. This is:</p>
<dl>
<dd><b>C</b>ondom use, for those who engage in risky behavior,</dd>
<dd><b>N</b>eedles, use clean ones,</dd>
<dd><b>N</b>egotiating skills; negotiating safer sex with a partner and empowering women to make smart choices.</dd>
</dl>
<p>Criticism of the ABC approach is widespread because a faithful partner of an unfaithful partner is at risk of contracting HIV.<sup id="_ref-EconomistABC_0" class="reference"><a  title="">[60]</a></sup></p>
<p>Current research is clarifying the relationship between male <a href="/wiki/Circumcision.html" title="Circumcision">circumcision</a> and HIV in differing social and cultural contexts.<sup id="_ref-Siegfred_0" class="reference"><a  title="">[61]</a></sup> UNAIDS believes that it is premature to recommend male circumcision services as part of HIV prevention programs<sup id="_ref-WHOcircumcision_0" class="reference"><a  title="">[62]</a></sup> even though male circumcision may lead to a reduction of infection risk in heterosexual men by up to 60%.<sup id="_ref-Williams_0" class="reference"><a  title="">[63]</a></sup> Moreover, South African medical experts are concerned that the repeated use of unsterilized blades in the ritual circumcision of adolescent boys may be spreading HIV.<sup id="_ref-Kaisercircum_0" class="reference"><a  title="">[64]</a></sup></p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Exposure to infected body fluids">edit</a>]</div>
<p><a name="Exposure_to_infected_body_fluids" id="Exposure_to_infected_body_fluids"></a></p>
<h3>Exposure to infected body fluids</h3>
<p>This transmission route is particularly relevant to <a href="/wiki/Intravenous_drug.html" title="Intravenous drug">intravenous drug</a> users, <a href="/wiki/Haemophilia.html" title="Haemophilia">hemophiliacs</a> and recipients of <a href="/wiki/Blood_transfusion.html" title="Blood transfusion">blood transfusions</a> and blood products. Sharing and reusing <a href="/wiki/Syringe.html" title="Syringe">syringes</a> contaminated with HIV-infected blood represents a major risk for infection with not only HIV, but also <a href="/wiki/Hepatitis_B.html" title="Hepatitis B">hepatitis B</a> and <a href="/wiki/Hepatitis_C.html" title="Hepatitis C">hepatitis C</a>. Needle sharing is the cause of one third of all new HIV-infections and 50% of hepatitis C infections in Northern America, <a href="/wiki/China.html" title="China">China</a>, and <a href="/wiki/Eastern_Europe.html" title="Eastern Europe">Eastern Europe</a>. The risk of being infected with HIV from a single prick with a needle that has been used on an HIV infected person is thought to be about 1 in 150 (<a href="/wiki/AIDS#Prevention.html" title="AIDS">see table above</a>). <a href="/wiki/Post-exposure_prophylaxis.html" title="Post-exposure prophylaxis">Post-exposure prophylaxis</a> with anti-HIV drugs can further reduce that small risk.<sup id="_ref-Fan_0" class="reference"><a  title="">[65]</a></sup> Health care workers (nurses, laboratory workers, doctors etc) are also concerned, although more rarely. This route can affect people who give and receive <a href="/wiki/Tattoo.html" title="Tattoo">tattoos</a> and <a href="/wiki/Piercing.html" title="Piercing">piercings</a>. Universal precautions are frequently not followed in both sub-Saharan Africa and much of Asia because of both a shortage of supplies and inadequate training. The WHO estimates that approximately 2.5% of all HIV infections in sub-Saharan Africa are transmitted through unsafe healthcare injections.<sup id="_ref-WHOJapan_0" class="reference"><a  title="">[66]</a></sup> Because of this, the <a href="/wiki/United_Nations_General_Assembly.html" title="United Nations General Assembly">United Nations General Assembly</a>, supported by universal medical opinion on the matter, has urged the nations of the world to implement universal precautions to prevent HIV transmission in health care settings.<sup id="_ref-PHR_0" class="reference"><a  title="">[67]</a></sup><sup id="_ref-UNGA_0" class="reference"><a  title="">[68]</a></sup></p>
<p>The risk of transmitting HIV to <a href="/wiki/Blood_transfusion.html" title="Blood transfusion">blood transfusion</a> recipients is extremely low in developed countries where improved donor selection and HIV screening is performed. However, according to the <a href="/wiki/WHO.html" title="WHO">WHO</a>, the overwhelming majority of the world's population does not have access to safe blood and "between 5% and 10% of HIV infections worldwide are transmitted through the transfusion of infected blood and blood products".<sup id="_ref-WHO070401_0" class="reference"><a  title="">[69]</a></sup></p>
<p>Medical workers who follow <a href="/wiki/Universal_precautions.html" title="Universal precautions">universal precautions</a> or body substance isolation such as wearing latex gloves when giving injections and washing the hands frequently can help prevent infection of HIV.</p>
<p>All AIDS-prevention organizations advise drug-users not to share needles and other material required to prepare and take drugs (including syringes, cotton balls, the spoons, water for diluting the drug, straws, crack pipes, etc). It is important that people use new or properly sterilized needles for each injection. Information on cleaning needles using bleach is available from health care and addiction professionals and from <a href="/wiki/Needle_exchange.html" title="Needle exchange">needle exchanges</a>. In some developed countries, clean needles are available free in some cities, at needle exchanges or <a href="/wiki/Safe_injection_site.html" title="Safe injection site">safe injection sites</a>. Additionally, many nations have decriminalized needle possession and made it possible to buy injection equipment from pharmacists without a prescription.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Mother-to-child transmission (MTCT)">edit</a>]</div>
<p><a name="Mother-to-child_transmission_.28MTCT.29" id="Mother-to-child_transmission_.28MTCT.29"></a></p>
<h3>Mother-to-child transmission (MTCT)</h3>
<p>The transmission of the virus from the mother to the child can occur <i><a href="/wiki/In_utero.html" title="In utero">in utero</a></i> during the last weeks of pregnancy and at childbirth. In the absence of treatment, the transmission rate between the mother to the child during pregnancy, labor and delivery is 25%. However, when the mother has access to antiretroviral therapy and gives birth by <a href="/wiki/Caesarean_section.html" title="Caesarean section">caesarean section</a>, the rate of transmission is just 1%.<sup id="_ref-Coovadia_1" class="reference"><a  title="">[42]</a></sup> A number of factors influence the risk of infection, particularly the viral load of the mother at birth (the higher the load, the higher the risk). <a href="/wiki/Breastfeeding.html" title="Breastfeeding">Breastfeeding</a> increases the risk of transmission by 10–15%. This risk depends on clinical factors and may vary according to the pattern and duration of breast-feeding.</p>
<p>Studies have shown that antiretroviral drugs, caesarean delivery and formula feeding reduce the chance of transmission of HIV from mother to child.<sup id="_ref-Sperling_0" class="reference"><a  title="">[70]</a></sup> Current recommendations state that when replacement feeding is acceptable, feasible, affordable, sustainable and safe, HIV-infected mothers should avoid breast-feeding their infant. However, if this is not the case, exclusive breast-feeding is recommended during the first months of life and discontinued as soon as possible.<sup id="_ref-UNAIDS2006_2" class="reference"><a  title="">[5]</a></sup> In 2005, around 700,000 children under 15 contracted HIV, mainly through MTCT, with 630,000 of these infections occurring in Africa.<sup id="_ref-avert_0" class="reference"><a  title="">[71]</a></sup> Of the estimated 2.3 million [1.7-3.5 million] children currently living with HIV, 2 million (almost 90%) live in sub-Saharan Africa.<sup id="_ref-UNAIDS2006_3" class="reference"><a  title="">[5]</a></sup></p>
<p>Prevention strategies are well known in developed countries, however, recent epidemiological and behavioral studies in Europe and North America have suggested that a substantial minority of young people continue to engage in high-risk practices and that despite HIV/AIDS knowledge, young people underestimate their own risk of becoming infected with HIV. <sup id="_ref-Dias_0" class="reference"><a  title="">[72]</a></sup> However, transmission of HIV between intravenous drug users has clearly decreased, and HIV transmission by blood transfusion has become quite rare in developed countries.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Treatment">edit</a>]</div>
<p><a name="Treatment" id="Treatment"></a></p>
<h2>Treatment</h2>
<p>There is currently no <a href="/wiki/HIV_vaccine.html" title="HIV vaccine">vaccine</a> or cure against <a href="/wiki/HIV.html" title="HIV">HIV</a> or AIDS. The only known methods of prevention are based on avoiding exposure to the virus or, failing that, an antiretroviral treatment directly after a highly significant exposure, called <a href="/wiki/Post-exposure_prophylaxis.html" title="Post-exposure prophylaxis">post-exposure prophylaxis</a> (PEP).<sup id="_ref-Fan_1" class="reference"><a  title="">[65]</a></sup> PEP has a very demanding four week schedule of dosage. It also has very unpleasant side effects including diarrhoea, malaise, nausea and fatigue.<sup id="_ref-PEPpocketguide_0" class="reference"><a  title="">[73]</a></sup></p>
<p>Current treatment for HIV infection consists of <a href="/wiki/Highly_active_antiretroviral_therapy.html" title="Highly active antiretroviral therapy">highly active antiretroviral therapy</a>, or HAART.<sup id="_ref-DhhsHivTreatment_0" class="reference"><a  title="">[74]</a></sup> This has been highly beneficial to many HIV-infected individuals since its introduction in 1996 when the protease inhibitor-based HAART initially became available.<sup id="_ref-Pallelal_0" class="reference"><a  title="">[75]</a></sup> Current optimal HAART options consist of combinations (or "cocktails") consisting of at least three drugs belonging to at least two types, or "classes," of <a href="/wiki/Anti-retroviral.html" title="Anti-retroviral">anti-retroviral</a> agents. Typical regimens consist of two <a href="/wiki/Nucleoside_analogue_reverse_transcriptase_inhibitor.html" title="Nucleoside analogue reverse transcriptase inhibitor">nucleoside analogue reverse transcriptase inhibitors</a> (NARTIs or NRTIs) plus either a <a href="/wiki/Protease_inhibitor_%28pharmacology%29.html" title="Protease inhibitor (pharmacology)">protease inhibitor</a> or a <a href="/wiki/Non-nucleoside_reverse_transcriptase_inhibitor.html" title="Non-nucleoside reverse transcriptase inhibitor">non-nucleoside reverse transcriptase inhibitor</a> (NNRTI). Because HIV disease progression in children is more rapid than in adults, and laboratory parameters are less predictive of risk for disease progression, particularly for young infants, treatment recommendations are more aggressive for children than for adults.<sup id="_ref-2005dhhsHivChildren_0" class="reference"><a  title="">[76]</a></sup> In developed countries where HAART is available, doctors assess the <a href="/wiki/Viral_load.html" title="Viral load">viral load</a>, rapidity in CD4 decline, and patient readiness while deciding when to recommend initiating treatment.<sup id="_ref-2005DhhsHivTreatment_0" class="reference"><a  title="">[77]</a></sup></p>
<div class="thumb tright">
<div style="width:102px;"><a  class="internal" title="Abacavir - a nucleoside analog reverse transcriptase inhibitors (NARTIs or NRTIs)"><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/4b/Abacavir_%28Ziagen%29_300mg.jpg/100px-Abacavir_%28Ziagen%29_300mg.jpg" alt="Abacavir - a nucleoside analog reverse transcriptase inhibitors (NARTIs or NRTIs)" width="100" height="100" longdesc="/wiki/Image:Abacavir_%28Ziagen%29_300mg.jpg" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a  class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="Enlarge" /></a></div>
<i><a href="/wiki/Abacavir.html" title="Abacavir">Abacavir</a></i> - a nucleoside analog reverse transcriptase inhibitors (NARTIs or NRTIs)</div>
</div>
</div>
<div class="thumb tright">
<div style="width:102px;"><a  class="internal" title="Atazanavir - a protease inhibitor"><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/7/78/Atazanavir_%28Reyataz%29200mg.jpg/100px-Atazanavir_%28Reyataz%29200mg.jpg" alt="Atazanavir - a protease inhibitor" width="100" height="82" longdesc="/wiki/Image:Atazanavir_%28Reyataz%29200mg.jpg" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a  class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="Enlarge" /></a></div>
<i><a href="/wiki/Atazanavir.html" title="Atazanavir">Atazanavir</a></i> - a protease inhibitor</div>
</div>
</div>
<p>HAART allows the stabilisation of the patient’s symptoms and viremia, but it neither cures the patient of HIV, nor alleviates the symptoms, and high levels of HIV-1, often HAART resistant, return once treatment is stopped.<sup id="_ref-martinez_0" class="reference"><a  title="">[78]</a></sup><sup id="_ref-Dybul_0" class="reference"><a  title="">[79]</a></sup> Moreover, it would take more than the lifetime of an individual to be cleared of HIV infection using HAART.<sup id="_ref-blankson_0" class="reference"><a  title="">[80]</a></sup> Despite this, many HIV-infected individuals have experienced remarkable improvements in their general health and quality of life, which has led to the plummeting of HIV-associated <a href="/wiki/Morbidity.html" title="Morbidity">morbidity</a> and <a href="/wiki/Mortality.html" title="Mortality">mortality</a>.<sup id="_ref-Pallelal_1" class="reference"><a  title="">[75]</a></sup><sup id="_ref-Wood_0" class="reference"><a  title="">[81]</a></sup><sup id="_ref-Chene_0" class="reference"><a  title="">[82]</a></sup> In the absence of HAART, progression from HIV infection to AIDS occurs at a <a href="/wiki/Median.html" title="Median">median</a> of between nine to ten years and the median survival time after developing AIDS is only 9.2 months.<sup id="_ref-Morgan2_4" class="reference"><a  title="">[7]</a></sup> Still, for some patients - and in many clinical cohorts this may be more than fifty percent of patients - HAART achieves far less than optimal results. This is due to a variety of reasons such as medication intolerance/side effects, prior ineffective antiretroviral therapy and infection with a drug-resistant strain of HIV. However, non-adherence and non-persistence with antiretroviral therapy is the major reason most individuals fail to get any benefit from and develop resistance to HAART.<sup id="_ref-becker_0" class="reference"><a  title="">[83]</a></sup> The reasons for non-adherence and non-persistence with HAART are varied and overlapping. Major psychosocial issues, such as poor access to medical care, inadequate social supports, psychiatric disease and drug abuse contribute to non-adherence. The complexity of these HAART regimens, whether due to pill number, dosing frequency, meal restrictions or other issues along with side effects that create intentional non-adherence also has a weighty impact.<sup id="_ref-Nieuwkerk_0" class="reference"><a  title="">[84]</a></sup><sup id="_ref-Kleeberger_0" class="reference"><a  title="">[85]</a></sup><sup id="_ref-heath_0" class="reference"><a  title="">[86]</a></sup> The side effects include <a href="/wiki/Lipodystrophy.html" title="Lipodystrophy">lipodystrophy</a>, <a href="/wiki/Dyslipidaemia.html" title="Dyslipidaemia">dyslipidaemia</a>, <a href="/wiki/Insulin_resistance.html" title="Insulin resistance">insulin resistance</a>, an increase in <a href="/wiki/Cardiovascular.html" title="Cardiovascular">cardiovascular</a> risks and <a href="/wiki/Birth_defect.html" title="Birth defect">birth defects</a>.<sup id="_ref-Montessori_0" class="reference"><a  title="">[87]</a></sup><sup id="_ref-Saitoh_0" class="reference"><a  title="">[88]</a></sup></p>
<p>Anti-retroviral drugs are expensive, and the majority of the world's infected individuals do not have access to medications and treatments for HIV and AIDS.<sup id="_ref-Ferrantelli_0" class="reference"><a  title="">[89]</a></sup> Research to improve current treatments includes decreasing side effects of current drugs, further simplifying drug regimens to improve adherence, and determining the best sequence of regimens to manage drug resistance. only a vaccine is postulated to be able to halt the pandemic. This is because a vaccine would possibly cost less, thus being affordable for developing countries, and would not require daily treatments.<sup id="_ref-Ferrantelli_1" class="reference"><a  title="">[89]</a></sup> However, after over 20 years of research, HIV-1 remains a difficult target for a vaccine.<sup id="_ref-Ferrantelli_2" class="reference"><a  title="">[89]</a></sup></p>
<p>A number of studies have shown that measures to prevent opportunistic infections can be beneficial when treating patients with HIV infection or AIDS. <a href="/wiki/Vaccination.html" title="Vaccination">Vaccination</a> against <a href="/wiki/Hepatitis.html" title="Hepatitis">hepatitis</a> A and B is advised for patients who are not infected with these viruses and are at risk of becoming infected.<sup id="_ref-Saltmarsh_0" class="reference"><a  title="">[90]</a></sup> In addition, AIDS patients should receive vaccination against <a href="/wiki/Streptococcus_pneumoniae.html" title="Streptococcus pneumoniae">Streptococcus pneumoniae</a> and should receive yearly vaccination against <a href="/wiki/Influenza_virus.html" title="Influenza virus">influenza virus</a>.<sup title="The text in the vicinity of this tag needs citation." class="noprint">[<a  title="Wikipedia:Citing sources"><i>citation&#160;needed</i></a>]</sup> Patients with substantial immunosuppression are also advised to receive prophylactic therapy for <a href="/wiki/Pneumocystis_jiroveci_pneumonia.html" title="Pneumocystis jiroveci pneumonia">Pneumocystis jiroveci pneumonia</a> (PCP), and many patients may benefit from prophylactic therapy for <a href="/wiki/Toxoplasmosis.html" title="Toxoplasmosis">toxoplasmosis</a> and <a href="/wiki/Cryptococcus.html" title="Cryptococcus">Cryptococcus</a> <a href="/wiki/Meningitis.html" title="Meningitis">meningitis</a>.</p>
<p>Various forms of <a href="/wiki/Alternative_medicine.html" title="Alternative medicine">alternative medicine</a> have been used to try to treat symptoms or to try to affect the course of the disease itself, although none is a substitute for conventional treatment.<sup id="_ref-Saltmarsh_1" class="reference"><a  title="">[90]</a></sup> In the first decade of the <a href="/wiki/Epidemic.html" title="Epidemic">epidemic</a> when no useful conventional treatment was available, a large number of people with AIDS experimented with <a href="/wiki/Alternative_medicine.html" title="Alternative medicine">alternative therapies</a>. The definition of "alternative therapies" in AIDS has changed since that time. Then, the phrase often referred to community-driven treatments, untested by government or pharmaceutical company research, that some hoped would directly suppress the virus or stimulate immunity against it. These kinds of approaches have become less common over time as the benefits of AIDS drugs have become more apparent. Examples of alternative medicine that people hoped would improve their symptoms or their quality of life include massage, herbal and flower remedies and <a href="/wiki/Acupuncture.html" title="Acupuncture">acupuncture</a>;<sup id="_ref-Saltmarsh_2" class="reference"><a  title="">[90]</a></sup> when used with conventional treatment, many now refer to these as "complementary" approaches. None of these treatments has been proven in controlled trials to have any effect in treating HIV or AIDS directly.<sup id="_ref-Mills_0" class="reference"><a  title="">[91]</a></sup> However, some may improve feelings of well-being in people who believe in their value. Additionally, people with AIDS, like people with other illnesses such as <a href="/wiki/Cancer.html" title="Cancer">cancer</a>, sometimes use <a href="/wiki/Marijuana.html" title="Marijuana">marijuana</a> to treat pain, combat nausea and stimulate appetite.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Epidemiology">edit</a>]</div>
<p><a name="Epidemiology" id="Epidemiology"></a></p>
<h2>Epidemiology</h2>
<dl>
<dd>
<div class="noprint"><i>Main article: <a href="/wiki/AIDS_pandemic.html" title="AIDS pandemic">AIDS pandemic</a></i></div>
</dd>
</dl>
<div class="thumb tright">
<div style="width:292px;"><a  class="internal" title="Prevalence of HIV among adults per country at the end of 2005  ██&#160;15-50% ██&#160;5-15% ██&#160;1-5% ██&#160;0.5-1.0% ██&#160;0.1-0.5% ██&#160;&lt;0.1% ██&#160;no data  "><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/d/d7/HIV_Epidem.png/290px-HIV_Epidem.png" alt="Prevalence of HIV among adults per country at the end of 2005  ██&#160;15-50% ██&#160;5-15% ██&#160;1-5% ██&#160;0.5-1.0% ██&#160;0.1-0.5% ██&#160;&lt;0.1% ██&#160;no data  " width="290" height="134" longdesc="/wiki/Image:HIV_Epidem.png" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a  class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="Enlarge" /></a></div>
Prevalence of HIV among adults per country at the end of 2005
<div class="references-small" style="-moz-column-count:2; column-count:2;"><span style="margin:0px;font-size:90%; display: block;"><span style="border:none;background-color:#800000;color:#800000;">██</span>&#160;15-50%</span> <span style="margin:0px;font-size:90%; display: block;"><span style="border:none;background-color:#FF0000;color:#FF0000;">██</span>&#160;5-15%</span> <span style="margin:0px;font-size:90%; display: block;"><span style="border:none;background-color:#E08040;color:#E08040;">██</span>&#160;1-5%</span> <span style="margin:0px;font-size:90%; display: block;"><span style="border:none;background-color:#e0c000;color:#e0c000;">██</span>&#160;0.5-1.0%</span> <span style="margin:0px;font-size:90%; display: block;"><span style="border:none;background-color:#e0e080;color:#e0e080;">██</span>&#160;0.1-0.5%</span> <span style="margin:0px;font-size:90%; display: block;"><span style="border:none;background-color:#00e080;color:#00e080;">██</span>&#160;&lt;0.1%</span> <span style="margin:0px;font-size:90%; display: block;"><span style="border:none;background-color:#c0c0c0;color:#c0c0c0;">██</span>&#160;no data</span></div>
</div>
</div>
</div>
<p>UNAIDS and the WHO estimate that AIDS has killed more than 25 million people since it was first recognized in 1981, making it one of the most destructive epidemics in recorded history. Despite recent, improved access to antiretroviral treatment and care in many regions of the world, the AIDS epidemic claimed an estimated 2.8 million (between 2.4 and 3.3 million) lives in 2005 of which more than half a million (570,000) were children.<sup id="_ref-UNAIDS2006_4" class="reference"><a  title="">[5]</a></sup></p>
<p>Globally, between 33.4 and 46 million people currently live with HIV.<sup id="_ref-UNAIDS2006_5" class="reference"><a  title="">[5]</a></sup> In 2005, between 3.4 and 6.2 million people were newly infected and between 2.4 and 3.3 million people with AIDS died, an increase from 2003 and the highest number since 1981.<sup id="_ref-UNAIDS2006_6" class="reference"><a  title="">[5]</a></sup></p>
<p><a href="/wiki/AIDS_pandemic#Sub-Saharan_Africa.html" title="AIDS pandemic">Sub-Saharan Africa</a> remains by far the worst affected region, with an estimated 21.6 to 27.4 million people currently living with HIV. Two million [1.5–3.0 million] of them are children younger than 15 years of age. More than 64% of all people living with HIV are in sub-Saharan Africa, as are more than three quarters (76%) of all women living with HIV. In 2005, there were 12.0 million [10.6–13.6 million] AIDS orphans living in sub-Saharan Africa 2005.<sup id="_ref-UNAIDS2006_7" class="reference"><a  title="">[5]</a></sup> <a href="/wiki/AIDS_pandemic#South_and_South-East_Asia.html" title="AIDS pandemic">South &amp; South East Asia</a> are second worst affected with 15%. AIDS accounts for the deaths of 500,000 children in this region. Two-thirds of HIV/AIDS infections in <a href="/wiki/Asia.html" title="Asia">Asia</a> occur in India, with an estimated 5.7 million infections (estimated 3.4 - 9.4 million) (0.9% of population), surpassing South Africa's estimated 5.5 million (4.9-6.1 million) (11.9% of population) infections, making it the country with the highest number of HIV infections in the world.<sup id="_ref-UNAIDS2006Annex_0" class="reference"><a  title="">[92]</a></sup> In the 35 African nations with the highest prevalence, average <a href="/wiki/Life_expectancy.html" title="Life expectancy">life expectancy</a> is 48.3 years— 6.5 years less than it would be without the disease.<sup id="_ref-UNAIDS2001_0" class="reference"><a  title="">[93]</a></sup></p>
<p>The latest evaluation report of the <a href="/wiki/World_Bank.html" title="World Bank">World Bank</a>'s Operations Evaluation Department assesses the effectiveness of the World Bank's country-level HIV/AIDS assistance, defined as policy dialogue, analytic work, and lending, with the explicit objective of reducing the scope or impact of the AIDS epidemic.<sup id="_ref-Worldbank_0" class="reference"><a  title="">[94]</a></sup> This is the first comprehensive evaluation of the World Bank's HIV/AIDS support to countries, from the beginning of the epidemic through mid-2004. Because the Bank's assistance is for implementation of government programs by government, it provides important insights on how national AIDS programs can be made more effective.</p>
<p>The development of <a href="/wiki/HAART.html" title="HAART">HAART</a> as effective therapy for HIV infection and AIDS has substantially reduced the death rate from this disease in those areas where it is widely available. This has created the misperception that the disease has gone away. In fact, as the life expectancy of persons with AIDS has increased in countries where HAART is widely used, the number of persons living with AIDS has increased substantially. In the United States, the number of persons with AIDS increased from about 35,000 in 1988 to over 220,000 in 1996.<sup id="_ref-CDC1996_0" class="reference"><a  title="">[95]</a></sup></p>
<p>In Africa, the number of MTCT and the prevalence of AIDS is beginning to reverse decades of steady progress in child survival. Countries such as <a href="/wiki/Uganda.html" title="Uganda">Uganda</a> are attempting to curb the MTCT epidemic by offering VCT (voluntary counseling and testing), PMTCT (prevention of mother-to-child transmission) and ANC (ante-natal care) services, which include the distribution of antiretroviral therapy.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Economic impact">edit</a>]</div>
<p><a name="Economic_impact" id="Economic_impact"></a></p>
<h2>Economic impact</h2>
<div class="thumb tright">
<div style="width:297px;"><a  class="internal" title="Changes in life expectancy in several African countries. &#160;Botswana&#160;Zimbabwe&#160;Kenya&#160;South Arica&#160;Uganda "><img src="http://upload.wikimedia.org/wikipedia/en/thumb/d/d6/Aids_in_africa_graph.gif/295px-Aids_in_africa_graph.gif" alt="Changes in life expectancy in several African countries. &#160;Botswana&#160;Zimbabwe&#160;Kenya&#160;South Arica&#160;Uganda " width="295" height="226" longdesc="/wiki/Image:Aids_in_africa_graph.gif" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a  class="internal" title="Enlarge"><img src="/skins-1.5/common/images/magnify-clip.png" width="15" height="11" alt="Enlarge" /></a></div>
Changes in life expectancy in several African countries.
<table style="border-collapse:collapse">
<tr>
<td style="padding:0">
<div style="border-width:0; border-top:2px dotted #000; border-top:red solid 2px; width:1em; position:relative; margin-bottom:-9px; top:.6em">&#160;</div>
</td>
<td style="padding:0 0 0 .2em">Botswana</td>
</tr>
</table>
<table style="border-collapse:collapse">
<tr>
<td style="padding:0">
<div style="border-width:0; border-top:2px dotted #000; border-top:darkgreen solid 2px; width:1em; position:relative; margin-bottom:-9px; top:.6em">&#160;</div>
</td>
<td style="padding:0 0 0 .2em">Zimbabwe</td>
</tr>
</table>
<table style="border-collapse:collapse">
<tr>
<td style="padding:0">
<div style="border-width:0; border-top:2px dotted #000; border-top:blue solid 2px; width:1em; position:relative; margin-bottom:-9px; top:.6em">&#160;</div>
</td>
<td style="padding:0 0 0 .2em">Kenya</td>
</tr>
</table>
<table style="border-collapse:collapse">
<tr>
<td style="padding:0">
<div style="border-width:0; border-top:2px dotted #000; border-top:black solid 2px; width:1em; position:relative; margin-bottom:-9px; top:.6em">&#160;</div>
</td>
<td style="padding:0 0 0 .2em">South Arica</td>
</tr>
</table>
<table style="border-collapse:collapse">
<tr>
<td style="padding:0">
<div style="border-width:0; border-top:2px dotted #000; border-top:grey solid 2px; width:1em; position:relative; margin-bottom:-9px; top:.6em">&#160;</div>
</td>
<td style="padding:0 0 0 .2em">Uganda</td>
</tr>
</table>
</div>
</div>
</div>
<p>HIV and AIDS retard <a href="/wiki/Economic_growth.html" title="Economic growth">economic growth</a> by destroying <a href="/wiki/Human_capital.html" title="Human capital">human capital</a>. UNAIDS has predicted outcomes for sub-Saharan Africa to the year 2025. These range from a plateau and eventual decline in deaths beginning around 2012 to a catastrophic continual growth in the <a href="/wiki/Death_rate.html" title="Death rate">death rate</a> with potentially 90 million cases of infection.<sup id="_ref-UNAIDS2006_8" class="reference"><a  title="">[5]</a></sup></p>
<p>Without proper <a href="/wiki/Nutrition.html" title="Nutrition">nutrition</a>, health care and medicine that is available in developed countries, large numbers of people in these countries are falling victim to AIDS. They will not only be unable to work, but will also require significant medical care. The forecast is that this will likely cause a collapse of economies and societies in the region. In some heavily infected areas, the epidemic has left behind many <a href="/wiki/Orphan.html" title="Orphan">orphans</a> cared for by elderly <a href="/wiki/Grandparent.html" title="Grandparent">grandparents</a>.</p>
<p>The increased <a href="/wiki/Mortality.html" title="Mortality">mortality</a> in this region will result in a <a href="/wiki/Population_decline.html" title="Population decline">smaller skilled population</a> and <a href="/wiki/Labor_force.html" title="Labor force">labor force</a>.<sup id="_ref-Greener_0" class="reference"><a  title="">[96]</a></sup> This smaller <a href="/wiki/Labor_force.html" title="Labor force">labor force</a> will be predominantly young people, with reduced knowledge and <a href="/wiki/Work_experience.html" title="Work experience">work experience</a> leading to reduced productivity. An increase in workers’ time off to look after sick family members or for sick leave will also lower productivity. Increased mortality will also weaken the mechanisms that generate human capital and <a href="/wiki/Investment.html" title="Investment">investment</a> in people, through loss of <a href="/wiki/Income.html" title="Income">income</a> and the death of parents.<sup id="_ref-Greener_1" class="reference"><a  title="">[96]</a></sup> By killing off mainly young adults, AIDS seriously weakens the <a href="/wiki/Tax.html" title="Tax">taxable</a> population, reducing the resources available for <a href="/wiki/Public_expenditure.html" title="Public expenditure">public expenditures</a> such as education and health services not related to AIDS resulting in increasing pressure for the state's finances and slower growth of the economy. This results in a slower growth of the tax base, an effect that will be reinforced if there are growing expenditures on treating the sick, training (to replace sick workers), sick pay and caring for AIDS orphans. This is especially true if the sharp increase in adult mortality shifts the responsibility and blame from the family to the government in caring for these orphans.</p>
<p>On the level of the household, AIDS results in both the loss of income and increased spending on healthcare by the household. The income effects of this lead to spending reduction as well as a substitution effect away from education and towards healthcare and funeral spending. A study in <a href="/wiki/C%C3%B4te_d%27Ivoire.html" title="Côte d'Ivoire">Côte d'Ivoire</a> showed that households with an HIV/AIDS patient spent twice as much on medical expenses as other households.<sup id="_ref-Bollinger_0" class="reference"><a  title="">[97]</a></sup></p>
<p>UNAIDS, WHO and the <a href="/wiki/United_Nations_Development_Programme.html" title="United Nations Development Programme">United Nations Development Programme</a> have documented a correlation between the decreasing life expectancies and the lowering of <a href="/wiki/Gross_national_product.html" title="Gross national product">gross national product</a> in many African countries with prevalence rates of 10% or more. Indeed, since 1992 predictions that AIDS would slow <a href="/wiki/Economic_growth.html" title="Economic growth">economic growth</a> in these countries have been published. The degree of impact depended on assumptions about the extent to which illness would be funded by savings and who would be infected.<sup id="_ref-WBank_0" class="reference"><a  title="">[98]</a></sup> Conclusions reached from models of the growth trajectories of 30 sub-Saharan economies over the period 1990–2025 were that the economic growth rates of these countries would be between 0.56 and 1.47% lower. The impact on <a href="/wiki/Gross_domestic_product.html" title="Gross domestic product">gross domestic product</a> (GDP) per capita was less conclusive. However, in 2000, the rate of growth of Africa's per capita GDP was in fact reduced by 0.7% per year from 1990–1997 with a further 0.3% per year lower in countries also affected by <a href="/wiki/Malaria.html" title="Malaria">malaria</a>.<sup id="_ref-Bonnel_0" class="reference"><a  title="">[99]</a></sup> The forecast now is that the growth of GDP for these countries will undergo a further reduction of between 0.5 and 2.6% per annum.<sup id="_ref-Greener_2" class="reference"><a  title="">[96]</a></sup> However, these estimates may be an underestimate, as they do not look at the effects on output <a href="/wiki/Per_capita.html" title="Per capita">per capita</a>.<sup id="_ref-eldis_0" class="reference"><a  title="">[100]</a></sup></p>
<p>Many governments in sub-Saharan Africa denied that there was a problem for years, and are only now starting to work towards solutions. Underfunding is a problem in all areas of HIV prevention when compared to even conservative estimates of the problems.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Stigma">edit</a>]</div>
<p><a name="Stigma" id="Stigma"></a></p>
<h2>Stigma</h2>
<p>AIDS stigma exists around the world in a variety of ways, including <a href="/wiki/Ostracism.html" title="Ostracism">ostracism</a>, <a href="/wiki/Rejection.html" title="Rejection">rejection</a>, <a href="/wiki/Discrimination.html" title="Discrimination">discrimination</a> and <a href="/wiki/Avoidance.html" title="Avoidance">avoidance</a> of HIV infected people; compulsory HIV testing without prior <a href="/wiki/Consent.html" title="Consent">consent</a> or protection of <a href="/wiki/Confidentiality.html" title="Confidentiality">confidentiality</a>; violence against HIV infected individuals or people who are perceived to be infected with HIV; and the <a href="/wiki/Quarantine.html" title="Quarantine">quarantine</a> of HIV infected individuals.<sup id="_ref-UNAIDS2006Ch4_0" class="reference"><a  title="">[101]</a></sup></p>
<p>AIDS stigma has been further divided into the following three categories:</p>
<ol>
<li>Instrumental AIDS stigma—a reflection of the fear and apprehension that are likely to be associated with any deadly and transmissible illness.<sup id="_ref-Herek1999_0" class="reference"><a  title="">[102]</a></sup></li>
<li>Symbolic AIDS stigma—the use of HIV/AIDS to express attitudes toward the social groups or lifestyles perceived to be associated with the disease.<sup id="_ref-Herek1999_1" class="reference"><a  title="">[102]</a></sup></li>
<li>Courtesy AIDS stigma—stigmatization of people connected to the issue of HIV/AIDS or HIV- positive people.<sup id="_ref-Snyder_0" class="reference"><a  title="">[103]</a></sup></li>
</ol>
<p>Often, AIDS stigma is expressed in conjunction with one or more other stigmas, particularly those associated with <a href="/wiki/Homosexuality.html" title="Homosexuality">homosexuality</a>, <a href="/wiki/Bisexuality.html" title="Bisexuality">bisexuality</a>, and intravenous drug use.</p>
<p>In many <a href="/wiki/Developed_country.html" title="Developed country">developed countries</a>, there is an association between AIDS and <a href="/wiki/Homosexuality.html" title="Homosexuality">homosexuality</a> or <a href="/wiki/Bisexuality.html" title="Bisexuality">bisexuality</a>, and this association is correlated with higher levels of sexual prejudice such as <a href="/wiki/Homophobia.html" title="Homophobia">anti-homosexual</a> attitudes.<sup id="_ref-Herek_0" class="reference"><a  title="">[104]</a></sup> There is also a perceived association between all male-male sexual behavior and AIDS, even sex between two uninfected men.<sup id="_ref-Herek1999_2" class="reference"><a  title="">[102]</a></sup></p>
<dl>
<dd><i>For more details on this topic, see <a  class="external text" title="http://hab.hrsa.gov/publications/stigma/introduction.htm">Stigma and HIV-AIDS, A review of the literature</a></i> <sup id="_ref-HRSA_0" class="reference"><a  title="">[105]</a></sup></dd>
</dl>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Origin of HIV">edit</a>]</div>
<p><a name="Origin_of_HIV" id="Origin_of_HIV"></a></p>
<h2>Origin of HIV</h2>
<dl>
<dd>
<div class="noprint"><i>Main article: <a href="/wiki/AIDS_origin.html" title="AIDS origin">AIDS origin</a></i></div>
</dd>
</dl>
<p>The AIDS epidemic was discovered <a href="/wiki/June_5.html" title="June 5">June 5</a>, <a href="/wiki/1981.html" title="1981">1981</a>, when the U.S. <a href="/wiki/Centers_for_Disease_Control_and_Prevention.html" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a> reported a cluster of <a href="/wiki/Pneumocystis_jiroveci_pneumonia.html" title="Pneumocystis jiroveci pneumonia"><i>Pneumocystis carinii</i> pneumonia</a> (now classified as Pneumocystis jiroveci pneumonia) in five homosexual men in <a href="/wiki/Los_Angeles.html" title="Los Angeles">Los Angeles</a>.<sup id="_ref-MMWR2_0" class="reference"><a  title="">[106]</a></sup> Originally dubbed GRID, or Gay-Related <a href="/wiki/Immunodeficiency.html" title="Immunodeficiency">Immune Deficiency</a>, health authorities soon realized that nearly half of the people identified with the syndrome were not homosexual men. In 1982, the CDC introduced the term AIDS to describe the newly recognized syndrome.</p>
<p>Three of the earliest known instances of HIV infection are as follows:</p>
<ol>
<li>A plasma sample taken in 1959 from an adult male living in what is now the Democratic Republic of Congo.<sup id="_ref-Zhu_0" class="reference"><a  title="">[107]</a></sup></li>
<li>HIV found in tissue samples from a 15 year old African-American teenager who died in St. Louis in 1969.<sup id="_ref-Kolata_0" class="reference"><a  title="">[108]</a></sup></li>
<li>HIV found in tissue samples from a <a href="/wiki/Norwegian.html" title="Norwegian">Norwegian</a> sailor who died around 1976.<sup id="_ref-HooperBMJ_0" class="reference"><a  title="">[109]</a></sup></li>
</ol>
<p>Two species of HIV infect humans: <a href="/wiki/HIV-1.html" title="HIV-1">HIV-1</a> and <a href="/wiki/HIV-2.html" title="HIV-2">HIV-2</a>. HIV-1 is more virulent and more easily transmitted. HIV-1 is the source of the majority of HIV infections throughout the world, while HIV-2 is not as easily transmitted and is largely confined to <a href="/wiki/West_Africa.html" title="West Africa">West Africa</a>.<sup id="_ref-Reeves_0" class="reference"><a  title="">[110]</a></sup> Both HIV-1 and HIV-2 are of <a href="/wiki/Primate.html" title="Primate">primate</a> origin. The origin of HIV-1 is the <a href="/wiki/Common_Chimpanzee.html" title="Common Chimpanzee">Central Common Chimpanzee</a> (<i>Pan troglodytes troglodytes</i>) found in southern <a href="/wiki/Cameroon.html" title="Cameroon">Cameroon</a>.<sup id="_ref-Keele_0" class="reference"><a  title="">[111]</a></sup> It is established that HIV-2 originated from the <a href="/wiki/Sooty_Mangabey.html" title="Sooty Mangabey">Sooty Mangabey</a> (<i>Cercocebus atys</i>), an <a href="/wiki/Old_World_monkey.html" title="Old World monkey">Old World monkey</a> of <a href="/wiki/Guinea_Bissau.html" title="Guinea Bissau">Guinea Bissau</a>, <a href="/wiki/Gabon.html" title="Gabon">Gabon</a>, and Cameroon.</p>
<p>Although a variety of theories exist explaining the transfer of HIV to humans, there is no widely accepted scientific consensus of any single hypothesis and the topic remains controversial. Freelance journalist <a href="/wiki/Tom_Curtis.html" title="Tom Curtis">Tom Curtis</a> discussed one currently controversial possibility for the origin of HIV/AIDS in a 1992 <a href="/wiki/Rolling_Stone.html" title="Rolling Stone">Rolling Stone</a> magazine article. He put forward what is now known as the <a href="/wiki/OPV_AIDS_hypothesis.html" title="OPV AIDS hypothesis">OPV AIDS hypothesis</a>, which suggests that AIDS was inadvertently caused in the late 1950s in the <a href="/wiki/Belgian_Congo.html" title="Belgian Congo">Belgian Congo</a> by <a href="/wiki/Hilary_Koprowski.html" title="Hilary Koprowski">Hilary Koprowski</a>'s research into a <a href="/wiki/Polio.html" title="Polio">polio</a> <a href="/wiki/Vaccine.html" title="Vaccine">vaccine</a>.<sup id="_ref-Curtis_0" class="reference"><a  title="">[112]</a></sup> Although subsequently retracted due to <a href="/wiki/Libel.html" title="Libel">libel</a> issues surrounding its claims, the Rolling Stone article motivated another freelance journalist, <a href="/wiki/Edward_Hooper.html" title="Edward Hooper">Edward Hooper</a>, to probe more deeply into this subject. Hooper's research resulted in his publishing a 1999 book, <i>The River</i>, in which he alleged that an experimental oral <a href="/wiki/Polio.html" title="Polio">polio</a> <a href="/wiki/Vaccine.html" title="Vaccine">vaccine</a> prepared using <a href="/wiki/Chimpanzee.html" title="Chimpanzee">chimpanzee</a> <a href="/wiki/Kidney.html" title="Kidney">kidney</a> tissue was the route through which <a href="/wiki/Simian_immunodeficiency_virus.html" title="Simian immunodeficiency virus">simian immunodeficiency virus</a> (SIV) crossed into humans to become HIV, thus starting the human AIDS pandemic.<sup id="_ref-Hooper_0" class="reference"><a  title="">[113]</a></sup> Subsequently, this hypothesis has been refuted by examination of these original polio vaccine stocks and establishing that they do not contain material of chimpanzee origin.<sup id="_ref-Berry_0" class="reference"><a  title="">[114]</a></sup></p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Alternative hypotheses">edit</a>]</div>
<p><a name="Alternative_hypotheses" id="Alternative_hypotheses"></a></p>
<h2>Alternative hypotheses</h2>
<dl>
<dd>
<div class="noprint"><i>Main article: <a href="/wiki/AIDS_reappraisal.html" title="AIDS reappraisal">AIDS reappraisal</a></i></div>
</dd>
</dl>
<p>A small minority of scientists and activists question the connection between HIV and AIDS,<sup id="_ref-Duesberg_0" class="reference"><a  title="">[115]</a></sup> the existence of HIV itself,<sup id="_ref-Papadopulos_0" class="reference"><a  title="">[116]</a></sup> or the validity of current testing methods. These claims are considered unsupported by most of the scientific community, who accuse the dissenters of selectively ignoring evidence in favor of HIV's role in AIDS and irresponsibly posing a threat to <a href="/wiki/Public_health.html" title="Public health">public health</a> by discouraging HIV testing and proven treatments.<sup id="_ref-Cohen_0" class="reference"><a  title="">[117]</a></sup><sup id="_ref-Kaiser_0" class="reference"><a  title="">[118]</a></sup></p>
<p>AIDS dissidents assert that the current mainstream approach to AIDS, based on HIV causation, has resulted in inaccurate diagnoses, psychological terror, toxic treatments, and a squandering of public funds.<sup id="_ref-controversy_0" class="reference"><a  title="">[119]</a></sup> Dissident views have been widely rejected,<sup id="_ref-Cohenseries_0" class="reference"><a  title="">[120]</a></sup><sup id="_ref-NIAIDlink_0" class="reference"><a  title="">[121]</a></sup> and are considered <a href="/wiki/Pseudoscience.html" title="Pseudoscience">pseudoscience</a> by the mainstream scientific community.</p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Common misconceptions">edit</a>]</div>
<p><a name="Common_misconceptions" id="Common_misconceptions"></a></p>
<h2>Common misconceptions</h2>
<dl>
<dd><i>Main article: <a href="/wiki/Common_misconceptions_about_HIV_and_AIDS.html" title="Common misconceptions about HIV and AIDS">Common misconceptions about HIV and AIDS</a></i></dd>
</dl>
<p>A number of misconceptions have arisen surrounding HIV/AIDS. Three of the most common are that AIDS can spread through casual contact, sexual intercourse with a virgin will cure AIDS, and HIV can infect only homosexual men and drug users.</p>
<p>One possibility for the misconception that AIDS infects only homosexual men is that AIDS was termed Gay Related Immune Deficiency Syndrome when it was first recognized in 1981 (it was subsequently renamed after it was recognised that there were methods of transmission other than male-male intercourse). HIV appears to have entered the <a href="/wiki/United_States.html" title="United States">United States</a> around the late 1960s and seems to have then been unknowingly spread by people throughout the U.S. and <a href="/wiki/Europe.html" title="Europe">Europe</a>. In a survey on AIDS conducted in 1983 in <a href="/wiki/Belgium.html" title="Belgium">Belgium</a>, <a href="/wiki/Denmark.html" title="Denmark">Denmark</a>, <a href="/wiki/Finland.html" title="Finland">Finland</a>, <a href="/wiki/France.html" title="France">France</a>, <a href="/wiki/Germany.html" title="Germany">Germany</a>, <a href="/wiki/Italy.html" title="Italy">Italy</a>, the <a href="/wiki/Netherlands.html" title="Netherlands">Netherlands</a>, <a href="/wiki/Norway.html" title="Norway">Norway</a>, <a href="/wiki/Sweden.html" title="Sweden">Sweden</a>, <a href="/wiki/Switzerland.html" title="Switzerland">Switzerland</a>, and the <a href="/wiki/United_Kingdom.html" title="United Kingdom">United Kingdom</a> a slight majority of those infected with HIV were male homosexuals (58% of all cases).<sup id="_ref-Glauser_0" class="reference"><a  title="">[122]</a></sup></p>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: Notes and references">edit</a>]</div>
<p><a name="Notes_and_references" id="Notes_and_references"></a></p>
<h2>Notes and references</h2>
<div class="references-small" style="-moz-column-count:2; column-count:2;">
<ol class="references">
<li id="_note-Marx"><b><a  title="">^</a></b> <cite style="font-style:normal">Marx, J. L. (1982). "New disease baffles medical community". <i>Science</i> <b>217</b> (4560): 618-621. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7089584&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-CDCtransmission"><b><a  title="">^</a></b> <a href="/wiki/Divisions_of_HIV/AIDS_Prevention.html" title="Divisions of HIV/AIDS Prevention">Divisions of HIV/AIDS Prevention</a> (2003). <a  class="external text" title="http://www.cdc.gov/HIV/pubs/facts/transmission.htm">HIV and Its Transmission</a>. <a href="/wiki/Centers_for_Disease_Control_%26_Prevention.html" title="Centers for Disease Control &amp; Prevention">Centers for Disease Control &amp; Prevention</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/May_23.html" title="May 23">05-23</a>.</li>
<li id="_note-sfaf"><b><a  title="">^</a></b> <a  class="new" title="San Francisco AIDS Foundation">San Francisco AIDS Foundation</a> (<a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/April_14.html" title="April 14">04-14</a>). <a  class="external text" title="http://www.sfaf.org/aids101/transmission.html">How HIV is spread</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/May_23.html" title="May 23">05-23</a>.</li>
<li id="_note-Gao"><b><a  title="">^</a></b> <cite style="font-style:normal">Gao, F., Bailes, E., Robertson, D. L., Chen, Y., Rodenburg, C. M., Michael, S. F., Cummins, L. B., Arthur, L. O., Peeters, M., Shaw, G. M., Sharp, P. M. and Hahn, B. H. (1999). "Origin of HIV-1 in the Chimpanzee Pan troglodytes troglodytes". <i>Nature</i> <b>397</b> (6718): 436-441. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9989410&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a> <a href="/wiki/Digital_object_identifier.html" title="Digital object identifier">DOI</a>:<a  class="external text" title="http://dx.doi.org/10.1038/17130">10.1038/17130</a>.</cite></li>
<li id="_note-UNAIDS2006">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a>&#160;<a  title=""><sup><i><b>c</b></i></sup></a>&#160;<a  title=""><sup><i><b>d</b></i></sup></a>&#160;<a  title=""><sup><i><b>e</b></i></sup></a>&#160;<a  title=""><sup><i><b>f</b></i></sup></a>&#160;<a  title=""><sup><i><b>g</b></i></sup></a>&#160;<a  title=""><sup><i><b>h</b></i></sup></a>&#160;<a  title=""><sup><i><b>i</b></i></sup></a> <cite class="book" style="font-style:normal"><a href="/wiki/UNAIDS.html" title="UNAIDS">UNAIDS</a> (2006). “<a  class="external text" title="http://data.unaids.org/pub/GlobalReport/2006/2006_GR_CH02_en.pdf">Overview of the global AIDS epidemic</a>”, <i>2006 Report on the global AIDS epidemic</i> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_8.html" title="June 8">06-08</a>.</cite></li>
<li id="_note-Palella"><b><a  title="">^</a></b> <cite style="font-style:normal">Palella, F. J. Jr, Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman and D. J., Holmberg, S. D. (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators". <i>N. Engl. J. Med</i> <b>338</b> (13): 853-860. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9516219&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Morgan2">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a>&#160;<a  title=""><sup><i><b>c</b></i></sup></a>&#160;<a  title=""><sup><i><b>d</b></i></sup></a>&#160;<a  title=""><sup><i><b>e</b></i></sup></a> <cite style="font-style:normal">Morgan, D., Mahe, C., Mayanja, B., Okongo, J. M., Lubega, R. and Whitworth, J. A. (2002). "HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?". <i>AIDS</i> <b>16</b> (4): 597-632. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11873003&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Clerici">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Clerici, M., Balotta, C., Meroni, L., Ferrario, E., Riva, C., Trabattoni, D., Ridolfo, A., Villa, M., Shearer, G.M., Moroni, M. and Galli, M. (1996). "Type 1 cytokine production and low prevalence of viral isolation correlate with long-term non progression in HIV infection". <i>AIDS Res. Hum. Retroviruses.</i> <b>12</b> (11): 1053-1061. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8827221&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Morgan">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Morgan, D., Mahe, C., Mayanja, B. and Whitworth, J. A. (2002). "Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study". <i>BMJ</i> <b>324</b> (7331): 193-196. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11809639&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Gendelman"><b><a  title="">^</a></b> <cite style="font-style:normal">Gendelman, H. E., Phelps, W., Feigenbaum, L., Ostrove, J. M., Adachi, A., Howley, P. M., Khoury, G., Ginsberg, H. S. and Martin, M. A. (1986). "Transactivation of the human immunodeficiency virus long terminal repeat sequences by DNA viruses". <i>Proc. Natl. Acad. Sci. U. S. A.</i> <b>83</b> (24): 9759-9763. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2432602&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Bentwich"><b><a  title="">^</a></b> <cite style="font-style:normal">Bentwich, Z., Kalinkovich., A. and Weisman, Z. (1995). "Immune activation is a dominant factor in the pathogenesis of African AIDS.". <i>Immunol. Today</i> <b>16</b> (4): 187-191. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7734046&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Tang">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Tang, J. and Kaslow, R. A. (2003). "The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy". <i>AIDS</i> <b>17</b> (Suppl 4): S51-S60. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15080180&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Quinones"><b><a  title="">^</a></b> <cite style="font-style:normal">Quiñones-Mateu, M. E., Mas, A., Lain de Lera, T., Soriano, V., Alcami, J., Lederman, M. M. and Domingo, E. (1998). "LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression". <i>Virus Research</i> <b>57</b> (1): 11-20. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9833881&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Campbell">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Campbell, G. R., Pasquier, E., Watkins, J., Bourgarel-Rey, V., Peyrot, V., Esquieu, D., Barbier, P., de Mareuil, J., Braguer, D., Kaleebu, P., Yirrell, D. L. and Loret E. P. (2004). "The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis". <i>J. Biol. Chem.</i> <b>279</b> (46): 48197-48204. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15331610&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Kaleebu"><b><a  title="">^</a></b> <cite style="font-style:normal">Kaleebu P, French N, Mahe C, Yirrell D, Watera C, Lyagoba F, Nakiyingi J, Rutebemberwa A, Morgan D, Weber J, Gilks C, Whitworth J. (2002). "Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda". <i>J. Infect. Dis.</i> <b>185</b> (9): 1244-1250. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12001041&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-WHO"><b><a  title="">^</a></b> <cite style="font-style:normal">World Health Organization (1990). "Interim proposal for a WHO staging system for HIV infection and disease". <i>WHO Wkly Epidem. Rec.</i> <b>65</b> (29): 221-228. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1974812&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-MMWR"><b><a  title="">^</a></b> <a href="/wiki/CDC.html" title="CDC">CDC</a> (1992). <a  class="external text" title="http://www.cdc.gov/mmwr/preview/mmwrhtml/00018871.htm">1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults</a>. CDC. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/February_9.html" title="February 9">02-09</a>.</li>
<li id="_note-Kumaranayake"><b><a  title="">^</a></b> <cite style="font-style:normal">Kumaranayake, L. and Watts, C. (2001). "Resource allocation and priority setting of HIV/AIDS interventions: addressing the generalized epidemic in sub-Saharan Africa". <i>J. Int. Dev.</i> <b>13</b> (4): 451-466. <a href="/wiki/Digital_object_identifier.html" title="Digital object identifier">DOI</a>:<a  class="external text" title="http://dx.doi.org/10.1002/jid.798">10.1002/jid.798</a>.</cite></li>
<li id="_note-Holmes"><b><a  title="">^</a></b> <cite style="font-style:normal">Holmes, C. B., Losina, E., Walensky, R. P., Yazdanpanah, Y., Freedberg, K. A. (2003). "Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa". <i>Clin. Infect. Dis.</i> <b>36</b> (5): 656-662. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12594648&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Guss"><b><a  title="">^</a></b> <cite style="font-style:normal">Guss, D. A. (1994). "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 1". <i>J. Emerg. Med.</i> <b>12</b> (3): 375-384. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8040596&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Guss2"><b><a  title="">^</a></b> <cite style="font-style:normal">Guss, D. A. (1994). "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 2". <i>J. Emerg. Med.</i> <b>12</b> (4): 491-497. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7963396&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Schneider"><b><a  title="">^</a></b> <cite style="font-style:normal">Schneider, M. F., Gange, S. J., Williams, C. M., Anastos, K., Greenblatt, R. M., Kingsley, L., Detels, R., and Munoz, A. (2005). "Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004". <i>AIDS</i> <b>19</b> (17): 2009-2018. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16260908&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Lawn">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Lawn, S. D. (2004). "AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection". <i>J. Infect. Dis.</i> <b>48</b> (1): 1-12. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14667787&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Campbell2"><b><a  title="">^</a></b> <cite style="font-style:normal">Campbell, G. R., Watkins, J. D., Esquieu, D., Pasquier, E., Loret, E. P. and Spector, S. A. (2005). "The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells". <i>J. Biol. Chem.</i> <b>280</b> (46): 38376-39382. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16155003&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Senkaali"><b><a  title="">^</a></b> <cite style="font-style:normal">Senkaali, D., Muwonge, R., Morgan, D., Yirrell, D., Whitworth, J. and Kaleebu, P. (2005). "The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort". <i>AIDS Res. Hum. Retroviruses.</i> <b>20</b> (9): 932-937. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15585080&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Feldman"><b><a  title="">^</a></b> <cite style="font-style:normal">Feldman, C. (2005). "Pneumonia associated with HIV infection". <i>Curr. Opin. Infect. Dis.</i> <b>18</b> (2): 165-170. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15735422&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Decker"><b><a  title="">^</a></b> <cite style="font-style:normal">Decker, C. F. and Lazarus, A. (2000). "Tuberculosis and HIV infection. How to safely treat both disorders concurrently". <i>Postgrad Med.</i> <b>108</b> (2): 57-60, 65-68. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10951746&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Zaidi"><b><a  title="">^</a></b> <cite style="font-style:normal">Zaidi, S. A. and Cervia, J. S. (2002). "Diagnosis and management of infectious esophagitis associated with human immunodeficiency virus infection". <i>J. Int. Assoc. Physicians AIDS Care (Chic Ill)</i> <b>1</b> (2): 53-62. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12942677&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Guerrant"><b><a  title="">^</a></b> <cite style="font-style:normal">Guerrant, R. L., Hughes, J. M., Lima, N. L., Crane, J. (1990). "Diarrhea in developed and developing countries: magnitude, special settings, and etiologies". <i>Rev. Infect. Dis.</i> <b>12</b> (Suppl 1): S41-S50. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2406855&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Luft"><b><a  title="">^</a></b> <cite style="font-style:normal">Luft, B. J. and Chua, A. (2000). "Central Nervous System Toxoplasmosis in HIV Pathogenesis, Diagnosis, and Therapy". <i>Curr. Infect. Dis. Rep.</i> <b>2</b> (4): 358-362. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11095878&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Sadler"><b><a  title="">^</a></b> <cite style="font-style:normal">Sadler, M. and Nelson, M. R. (1997). "Progressive multifocal leukoencephalopathy in HIV". <i>Int. J. STD AIDS</i> <b>8</b> (6): 351-357. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9179644&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Gray"><b><a  title="">^</a></b> <cite style="font-style:normal">Gray, F., Adle-Biassette, H., Chrétien, F., Lorin de la Grandmaison, G., Force, G., Keohane, C. (2001). "Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments". <i>Clin. Neuropathol.</i> <b>20</b> (4): 146-155. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11495003&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Grant"><b><a  title="">^</a></b> <cite class="book" style="font-style:normal">Grant, I., Sacktor, H., and McArthur, J. (2005). “<a  class="external text" title="http://www.hnrc.ucsd.edu/publications_pdf/2005grant1.pdf">HIV neurocognitive disorders</a>”, H. E. Gendelman, I. Grant, I. Everall, S. A. Lipton, and S. Swindells. (ed.) <i>The Neurology of AIDS</i> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>), 2nd, London, U.K.: Oxford University Press, 357-373. <a  class="internal">ISBN 0-19-852610-5</a>.</cite></li>
<li id="_note-Satischandra"><b><a  title="">^</a></b> <cite style="font-style:normal">Satishchandra, P., Nalini, A., Gourie-Devi, M., Khanna, N., Santosh, V., Ravi, V., Desai, A., Chandramuki, A., Jayakumar, P. N., and Shankar, S. K. (2000). "Profile of neurologic disorders associated with HIV/AIDS from Bangalore, south India (1989-96)". <i>Indian J. Med. Res.</i> <b>11</b>: 14-23. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=10793489&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Wadia"><b><a  title="">^</a></b> <cite style="font-style:normal">Wadia, R. S., Pujari, S. N., Kothari, S., Udhar, M., Kulkarni, S., Bhagat, S., and Nanivadekar, A. (2001). "Neurological manifestations of HIV disease". <i>J. Assoc. Physicians India</i> <b>49</b>: 343-348. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11291974&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Boshoff"><b><a  title="">^</a></b> <cite style="font-style:normal">Boshoff, C. and Weiss, R. (2002). "AIDS-related malignancies". <i>Nat. Rev. Cancer</i> <b>2</b> (5): 373-382. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12044013&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Yarchoan"><b><a  title="">^</a></b> <cite style="font-style:normal">Yarchoan, R., Tosatom G. and Littlem R. F. (2005). "Therapy insight: AIDS-related malignancies - the influence of antiviral therapy on pathogenesis and management". <i>Nat. Clin. Pract. Oncol.</i> <b>2</b> (8): 406-415. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16130937&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Bonnet"><b><a  title="">^</a></b> <cite style="font-style:normal">Bonnet, F., Lewden, C., May, T., Heripret, L., Jougla, E., Bevilacqua, S., Costagliola, D., Salmon, D., Chene, G. and Morlat, P. (2004). "Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy". <i>Cancer</i> <b>101</b> (2): 317-324. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15241829&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Skoulidis"><b><a  title="">^</a></b> <cite style="font-style:normal">Skoulidis, F., Morgan, M. S., and MacLeod, K. M. (2004). "Penicillium marneffei: a pathogen on our doorstep?". <i>J. R. Soc. Med.</i> <b>97</b> (2): 394-396. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15286196&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-MMWR3"><b><a  title="">^</a></b> <cite style="font-style:normal">Smith, D. K., Grohskopf, L. A., Black, R. J., Auerbach, J. D., Veronese, F., Struble, K. A., Cheever, L., Johnson, M., Paxton, L. A., Onorato, I. A. and Greenberg, A. E. (2005). "<a  class="external text" title="http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5402a1.htm">Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States</a>". <i>MMWR</i> <b>54</b> (RR02): 1-20.</cite></li>
<li id="_note-Donegan"><b><a  title="">^</a></b> <cite style="font-style:normal">Donegan, E., Stuart, M., Niland, J. C., Sacks, H. S., Azen, S. P., Dietrich, S. L., Faucett, C., Fletcher, M. A., Kleinman, S. H., Operskalski, E. A., et al. (1990). "Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations". <i>Ann. Intern. Med.</i> <b>113</b> (10): 733-739. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=2240875&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Coovadia">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Coovadia, H. (2004). "Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS". <i>N. Engl. J. Med.</i> <b>351</b> (3): 289-292. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15247337&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Kaplan"><b><a  title="">^</a></b> <cite style="font-style:normal">Kaplan, E. H. and Heimer, R. (1995). "HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data". <i>J. Acquir. Immune Defic. Syndr. Hum. Retrovirol.</i> <b>10</b> (2): 175-176. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7552482&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-ESG">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a>&#160;<a  title=""><sup><i><b>c</b></i></sup></a>&#160;<a  title=""><sup><i><b>d</b></i></sup></a> <cite style="font-style:normal">European Study Group on Heterosexual Transmission of HIV (1992). "Comparison of female to male and male to female transmission of HIV in 563 stable couples". <i>BMJ.</i> <b>304</b> (6830): 809-813. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1392708&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Varghese">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a>&#160;<a  title=""><sup><i><b>c</b></i></sup></a>&#160;<a  title=""><sup><i><b>d</b></i></sup></a>&#160;<a  title=""><sup><i><b>e</b></i></sup></a>&#160;<a  title=""><sup><i><b>f</b></i></sup></a> <cite style="font-style:normal">Varghese, B., Maher, J. E., Peterman, T. A., Branson, B. M. and Steketee, R. W. (2002). "Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use". <i>Sex. Transm. Dis.</i> <b>29</b> (1): 38-43. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11773877&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Bell"><b><a  title="">^</a></b> <cite style="font-style:normal">Bell, D. M. (1997). "Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview.". <i>Am. J. Med.</i> <b>102</b> (5B): 9-15. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9845490&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Leynaert"><b><a  title="">^</a></b> <cite style="font-style:normal">Leynaert, B., Downs, A. M. and de Vincenzi, I. (1998). "Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV". <i>Am. J. Epidemiol.</i> <b>148</b> (1): 88-96. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9663408&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Rothenberg"><b><a  title="">^</a></b> <cite style="font-style:normal">Rothenberg, R. B., Scarlett, M., del Rio, C., Reznik, D. and O'Daniels, C. (1998). "Oral transmission of HIV". <i>AIDS</i> <b>12</b> (16): 2095-2105. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9833850&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Vincenzi"><b><a  title="">^</a></b> <cite style="font-style:normal">Mastro TD, de Vincenzi I (1996). "Probabilities of sexual HIV-1 transmission". <i>AIDS</i> <b>10</b> (Suppl A): S75-S82. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8883613&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Laga">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Laga, M., Nzila, N., Goeman, J. (1991). "The interrelationship of sexually transmitted diseases and HIV infection: implications for the control of both epidemics in Africa". <i>AIDS</i> <b>5</b> (Suppl 1): S55-S63. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=1669925&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Tovanabutra"><b><a  title="">^</a></b> <cite style="font-style:normal">Tovanabutra, S., Robison, V., Wongtrakul, J., Sennum, S., Suriyanon, V., Kingkeow, D., Kawichai, S., Tanan, P., Duerr, A. and Nelson, K. E. (2002). "Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand". <i>J. Acquir. Immune. Defic. Syndr.</i> <b>29</b> (3): 275-283. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11873077&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Sagar"><b><a  title="">^</a></b> <cite style="font-style:normal">Sagar, M., Lavreys, L., Baeten, J. M., Richardson, B. A., Mandaliya, K., Ndinya-Achola, J. O., Kreiss, J. K., and Overbaugh, J. (2004). "Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population". <i>AIDS</i> <b>18</b> (4): 615-619. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15090766&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Lavreys"><b><a  title="">^</a></b> <cite style="font-style:normal">Lavreys, L., Baeten, J. M., Martin, H. L. Jr., Overbaugh, J., Mandaliya, K., Ndinya-Achola, J., and Kreiss, J. K. (2004). "Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study". <i>AIDS</i> <b>18</b> (4): 695-697. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15090778&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Cayley"><b><a  title="">^</a></b> <cite style="font-style:normal">Cayley, W. E. Jr. (2004). "Effectiveness of condoms in reducing heterosexual transmission of HIV". <i>Am. Fam. Physician</i> <b>70</b> (7): 1268-1269. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15508535&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-HRW"><b><a  title="">^</a></b> <cite class="book" style="font-style:normal">Human Rights Watch (2005). “<a  class="external text" title="http://hrw.org/reports/2005/uganda0305/7.htm#_Toc98378385">Restrictions on Condoms</a>”, <i>The Less They Know, the Better</i>. New York NY: Human Rights Watch.</cite></li>
<li id="_note-Fisher"><b><a  title="">^</a></b> Fisher, I..&#160;"<a  class="external text" title="http://www.nytimes.com/2006/05/02/world/europe/02pope.html?_r=1&amp;ex=1147233600&amp;en=27a30199f9128ffd&amp;ei=5087%0A&amp;oref=slogin">Ideals Collide as Vatican Rethinks Condom Ban</a>", <i>The New York Times</i>, <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/May_2.html" title="May 2">05-02</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/May_8.html" title="May 8">05-08</a>.</li>
<li id="_note-catechism"><b><a  title="">^</a></b> <cite class="book" style="font-style:normal">Catholic Church (1997). “<a  class="external text" title="http://www.scborromeo.org/ccc/p3s2c2a6.htm#II">Offenses against chastity</a>”, <i>Catechism of the Catholic Church&#160;: Second Edition</i>. Vatican: Amministrazione Del Patrimonio Della Sede Apostolica, 2353. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_14.html" title="June 14">06-14</a>.</cite></li>
<li id="_note-Durex"><b><a  title="">^</a></b> <a href="/wiki/Durex.html" title="Durex">Durex</a>. <a  class="external text" title="http://www.durex.com/cm/assets/SexEdDownloads/Module_5_condoms.doc">Module 5/Guidelines for Educators</a> (<a href="/wiki/Microsoft_Word.html" title="Microsoft Word">Microsoft Word</a>). Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/April_17.html" title="April 17">04-17</a>.</li>
<li id="_note-WHOCondoms"><b><a  title="">^</a></b> <a href="/wiki/WHO.html" title="WHO">WHO</a> (August, 2003). <a  class="external text" title="http://www.wpro.who.int/media_centre/fact_sheets/fs_200308_Condoms.htm">Condom Facts and Figures</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/January_17.html" title="January 17">01-17</a>.</li>
<li id="_note-EconomistABC"><b><a  title="">^</a></b> <a href="/wiki/The_Economist.html" title="The Economist">The Economist</a> (2005). <a  class="external text" title="http://www.economist.com/opinion/displayStory.cfm?story_id=4223619">Too much morality, too little sense</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_28.html" title="March 28">03-28</a>.</li>
<li id="_note-Siegfred"><b><a  title="">^</a></b> <cite style="font-style:normal">Siegfried, N., Muller, M., Deeks, J., Volmink, J., Egger, M., Low, N., Walker, S. and Williamson, P. (2005). "HIV and male circumcision--a systematic review with assessment of the quality of studies". <i>Lancet Infect. Dis.</i> <b>5</b> (3): 165-173. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15766651&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-WHOcircumcision"><b><a  title="">^</a></b> <a href="/wiki/WHO.html" title="WHO">WHO</a> (2005). <a  class="external text" title="http://www.who.int/mediacentre/news/releases/2005/pr32/en/">UNAIDS statement on South African trial findings regarding male circumcision and HIV</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_28.html" title="March 28">03-28</a>.</li>
<li id="_note-Williams"><b><a  title="">^</a></b> <cite style="font-style:normal">Williams BG, Lloyd-Smith JO, Gouws E, Hankins C, Getz WM, Hargrove J, de Zoysa I, Dye C, Auvert B. (2006). "The Potential Impact of Male Circumcision on HIV in Sub-Saharan Africa.". <i>PLoS Med</i> <b>3</b> (7): e262. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16822094&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Kaisercircum"><b><a  title="">^</a></b> Various (2005). <a  class="external text" title="http://www.kaisernetwork.org/daily_reports/rep_index.cfm?DR_ID=31199">Repeated Use of Unsterilized Blades in Ritual Circumcision Might Contribute to HIV Spread in S. Africa, Doctors Say</a>. Kaisernetwork.org. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_28.html" title="March 28">03-28</a>.</li>
<li id="_note-Fan">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite class="book" style="font-style:normal">Fan, H. (2005). Fan, H., Conner, R. F. and Villarreal, L. P. eds <i>AIDS: science and society</i>, 4th, Boston, MA: Jones and Bartlett Publishers. <a  class="internal">ISBN 0-7637-0086-X</a>.</cite></li>
<li id="_note-WHOJapan"><b><a  title="">^</a></b> <a href="/wiki/WHO.html" title="WHO">WHO</a> (<a href="/wiki/2003.html" title="2003">2003</a>-<a href="/wiki/March_17.html" title="March 17">03-17</a>). <a  class="external text" title="http://64.233.179.104/search?q=cache:adH68_6JGG8J:tokyo.usembassy.gov//e/p/tp-20030317a3.html+site:tokyo.usembassy.gov+HIV+healthcare+injection&amp;hl=en&amp;gl=us&amp;ct=clnk&amp;cd=1">WHO, UNAIDS Reaffirm HIV as a Sexually Transmitted Disease</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/January_17.html" title="January 17">01-17</a>.</li>
<li id="_note-PHR"><b><a  title="">^</a></b> Physicians for Human Rights (<a href="/wiki/2003.html" title="2003">2003</a>-<a href="/wiki/March_13.html" title="March 13">03-13</a>). <a  class="external text" title="http://www.phrusa.org/campaigns/aids/who_031303.html">HIV Transmission in the Medical Setting: A White Paper by Physicians for Human Rights</a>. Partners in Health. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_1.html" title="March 1">03-01</a>.</li>
<li id="_note-UNGA"><b><a  title="">^</a></b> United Nations General Assembly (2001). <a  class="external text" title="http://www.un.org/ga/aids/coverage/FinalDeclarationHIVAIDS.html">Declaration of Commitment on HIV/AIDS <i>Global Crisis — Global Action</i></a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_1.html" title="March 1">03-01</a>.</li>
<li id="_note-WHO070401"><b><a  title="">^</a></b> <a href="/wiki/WHO.html" title="WHO">WHO</a> (2001). <a  class="external text" title="http://www.who.int/inf-pr-2000/en/pr2000-25.html">Blood safety....for too few</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/January_17.html" title="January 17">01-17</a>.</li>
<li id="_note-Sperling"><b><a  title="">^</a></b> <cite style="font-style:normal">Sperling, R. S., Shapirom D. E., Coombsm R. W., Todd, J. A., Herman, S. A., McSherry, G. D., O'Sullivan, M. J., Van Dyke, R. B., Jimenez, E., Rouzioux, C., Flynn, P. M. and Sullivan, J. L. (1996). "Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant". <i>N. Engl. J. Med.</i> <b>335</b> (22): 1621-1629. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=8965861&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-avert"><b><a  title="">^</a></b> Berry, S. (<a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_8.html" title="June 8">06-08</a>). <a  class="external text" title="http://www.avert.org/children.htm">Children, HIV and AIDS</a>. avert.org. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_15.html" title="June 15">06-15</a>.</li>
<li id="_note-Dias"><b><a  title="">^</a></b> <cite style="font-style:normal">Dias, S. F., Matos, M. G. and Goncalves, A. C. (2005). "Preventing HIV transmission in adolescents: an analysis of the Portuguese data from the Health Behaviour School-aged Children study and focus groups". <i>Eur. J. Public Health</i> <b>15</b> (3): 300-304. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15941747&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-PEPpocketguide"><b><a  title="">^</a></b> <a href="/wiki/Department_of_Health_and_Human_Services.html" title="Department of Health and Human Services">Department of Health and Human Services</a> (February, 2006). <a  class="external text" title="http://hab.hrsa.gov/tools/HIVpocketguide/PktGPEP.htm">A Pocket Guide to Adult HIV/AIDS Treatment February 2006 edition</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/September_1.html" title="September 1">09-01</a>.</li>
<li id="_note-DhhsHivTreatment"><b><a  title="">^</a></b> <a href="/wiki/Department_of_Health_and_Human_Services.html" title="Department of Health and Human Services">Department of Health and Human Services</a> (February, 2006). <a  class="external text" title="http://hab.hrsa.gov/tools/HIVpocketguide/PktGARTtables.htm">A Pocket Guide to Adult HIV/AIDS Treatment February 2006 edition</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/September_1.html" title="September 1">09-01</a>.</li>
<li id="_note-Pallelal">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a> <cite style="font-style:normal">Palella, F. J., Delaney, K. M., Moorman, A. C., Loveless, M. O., Fuhrer, J., Satten, G. A., Aschman, D. J. and Holmberg, S. D. (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection". <i>N. Engl. J. Med.</i> <b>338</b> (13): 853-860. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9516219&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-2005dhhsHivChildren"><b><a  title="">^</a></b> <a href="/wiki/Department_of_Health_and_Human_Services.html" title="Department of Health and Human Services">Department of Health and Human Services</a> Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children (<a href="/wiki/November_3.html" title="November 3">November 3</a>, <a href="/wiki/2005.html" title="2005">2005</a>). <a  class="external text" title="http://www.aidsinfo.nih.gov/ContentFiles/PediatricGuidelines_PDA.pdf">Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection</a> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/January_17.html" title="January 17">01-17</a>.</li>
<li id="_note-2005DhhsHivTreatment"><b><a  title="">^</a></b> <a href="/wiki/Department_of_Health_and_Human_Services.html" title="Department of Health and Human Services">Department of Health and Human Services</a> Panel on Clinical Practices for Treatment of HIV Infection (<a href="/wiki/October_6.html" title="October 6">October 6</a>, <a href="/wiki/2005.html" title="2005">2005</a>). <a  class="external text" title="http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf">Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents</a> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/January_17.html" title="January 17">01-17</a>.</li>
<li id="_note-martinez"><b><a  title="">^</a></b> <cite style="font-style:normal">Martinez-Picado, J., DePasquale, M. P., Kartsonis, N., Hanna, G. J., Wong, J., Finzi, D., Rosenberg, E., Gunthard, H. F., Sutton, L., Savara, A., Petropoulos, C. J., Hellmann, N., Walker, B. D., Richman, D. D., Siliciano, R. and D'Aquila, R. T. (2000). "Antiretroviral resistance during successful therapy of human immunodeficiency virus type 1 infection". <i>Proc. Natl. Acad. Sci. U. S. A.</i> <b>97</b> (20): 10948-10953. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11005867&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Dybul"><b><a  title="">^</a></b> <cite style="font-style:normal">Dybul, M., Fauci, A. S., Bartlett, J. G., Kaplan, J. E., Pau, A. K.; Panel on Clinical Practices for Treatment of HIV. (2002). "Guidelines for using antiretroviral agents among HIV-infected adults and adolescents". <i>Ann. Intern. Med.</i> <b>137</b> (5 Pt 2): 381-433. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12617573&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-blankson"><b><a  title="">^</a></b> <cite style="font-style:normal">Blankson, J. N., Persaud, D., Siliciano, R. F. (2002). "The challenge of viral reservoirs in HIV-1 infection". <i>Annu. Rev. Med.</i> <b>53</b>: 557-593. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11818490&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Wood"><b><a  title="">^</a></b> <cite style="font-style:normal">Wood, E., Hogg, R. S., Yip, B., Harrigan, P. R., O'Shaughnessy, M. V. and Montaner, J. S. (2003). "Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?". <i>AIDS</i> <b>17</b> (5): 711-720. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12646794&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Chene"><b><a  title="">^</a></b> <cite style="font-style:normal">Chene, G., Sterne, J. A., May, M., Costagliola, D., Ledergerber, B., Phillips, A. N., Dabis, F., Lundgren, J., D'Arminio Monforte, A., de Wolf, F., Hogg, R., Reiss, P., Justice, A., Leport, C., Staszewski, S., Gill, J., Fatkenheuer, G., Egger, M. E. and the Antiretroviral Therapy Cohort Collaboration. (2003). "Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies". <i>Lancet</i> <b>362</b> (9385): 679-686. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12957089&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-becker"><b><a  title="">^</a></b> <cite style="font-style:normal">Becker SL, Dezii CM, Burtcel B, Kawabata H, Hodder S. (2002). "Young HIV-infected adults are at greater risk for medication nonadherence". <i>MedGenMed.</i> <b>4</b> (3): 21. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12466764&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Nieuwkerk"><b><a  title="">^</a></b> <cite style="font-style:normal">Nieuwkerk, P., Sprangers, M., Burger, D., Hoetelmans, R. M., Hugen, P. W., Danner, S. A., van Der Ende, M. E., Schneider, M. M., Schrey, G., Meenhorst, P. L., Sprenger, H. G., Kauffmann, R. H., Jambroes, M., Chesney, M. A., de Wolf, F., Lange, J. M. and the ATHENA Project. (2001). "Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study". <i>Arch. Intern. Med.</i> <b>161</b> (16): 1962-1968. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11525698&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Kleeberger"><b><a  title="">^</a></b> <cite style="font-style:normal">Kleeberger, C., Phair, J., Strathdee, S., Detels, R., Kingsley, L. and Jacobson, L. P. (2001). "Determinants of Heterogeneous Adherence to HIV-Antiretroviral Therapies in the Multicenter AIDS Cohort Study". <i>J. Acquir. Immune Defic. Syndr.</i> <b>26</b> (1): 82-92. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=11176272&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-heath"><b><a  title="">^</a></b> <cite style="font-style:normal">Heath, K. V., Singer, J., O'Shaughnessy, M. V., Montaner, J. S. and Hogg, R. S. (2002). "Intentional Nonadherence Due to Adverse Symptoms Associated With Antiretroviral Therapy". <i>J. Acquir. Immune Defic. Syndr.</i> <b>31</b> (2): 211-217. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12394800&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Montessori"><b><a  title="">^</a></b> <cite style="font-style:normal">Montessori, V., Press, N., Harris, M., Akagi, L., Montaner, J. S. (2004). "Adverse effects of antiretroviral therapy for HIV infection.". <i>CMAJ</i> <b>170</b> (2): 229-238. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14734438&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Saitoh"><b><a  title="">^</a></b> <cite style="font-style:normal">Saitoh, A., Hull, A. D., Franklin, P. and Spector, S. A. (2005). "Myelomeningocele in an infant with intrauterine exposure to efavirenz". <i>J. Perinatol.</i> <b>25</b> (8): 555-556. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16047034&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Ferrantelli">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a>&#160;<a  title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal">Ferrantelli F, Cafaro A, Ensoli B. (2004). "Nonstructural HIV proteins as targets for prophylactic or therapeutic vaccines". <i>Curr Opin Biotechnol.</i> <b>15</b> (6): 543-556. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15560981&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Saltmarsh">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a>&#160;<a  title=""><sup><i><b>c</b></i></sup></a> <cite style="font-style:normal">Laurence J. (2006). "Hepatitis A and B virus immunization in HIV-infected persons". <i>AIDS Reader</i> <b>16</b> (1): 15-17. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16433468&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Mills"><b><a  title="">^</a></b> <cite style="font-style:normal">Mills, E., Wu, P. and Ernst, E. (2005). "Complementary therapies for the treatment of HIV: in search of the evidence.". <i>Int. J. STD AIDS.</i> <b>16</b> (6): 395-403. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15969772&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-UNAIDS2006Annex"><b><a  title="">^</a></b> <cite class="book" style="font-style:normal"><a href="/wiki/UNAIDS.html" title="UNAIDS">UNAIDS</a> (2006). “<a  class="external text" title="http://data.unaids.org/pub/GlobalReport/2006/2006_GR_ANN2_en.pdf">Annex 2: HIV/AIDS estimates and data, 2005</a>”, <i>2006 Report on the global AIDS epidemic</i> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_8.html" title="June 8">06-08</a>.</cite></li>
<li id="_note-UNAIDS2001"><b><a  title="">^</a></b> UNAIDS (2001). <a  class="external text" title="http://data.unaids.org/Publications/External-Documents/GAS26-rt3_en.pdf">Special Session of the General Assembly on HIV/AIDS Round table 3 Socio-economic impact of the epidemic and the strengthening of national capacities to combat HIV/AIDS</a> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_15.html" title="June 15">06-15</a>.</li>
<li id="_note-Worldbank"><b><a  title="">^</a></b> <a href="/wiki/World_Bank.html" title="World Bank">World Bank</a> (2005). <a  class="external text" title="http://www.worldbank.org/oed/aids/main_report.html">Evaluating the World Bank's Assistance for Fighting the HIV/AIDS Epidemic</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/January_17.html" title="January 17">01-17</a>.</li>
<li id="_note-CDC1996"><b><a  title="">^</a></b> <cite style="font-style:normal"><a href="/wiki/CDC.html" title="CDC">CDC</a> (1996). "<a  class="external text" title="http://www.cdc.gov/hiv/stats/hivsur82.pdf">U.S. HIV and AIDS cases reported through December 1996</a>" (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). <i>HIV/AIDS Surveillance Report</i> <b>8</b> (2): 1-40.</cite></li>
<li id="_note-Greener">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a>&#160;<a  title=""><sup><i><b>c</b></i></sup></a> <cite class="book" style="font-style:normal">Greener, R. (2002). “<a  class="external text" title="http://www.iaen.org/library/statepidemic/chapter7.pdf">AIDS and macroeconomic impact</a>”, S, Forsyth (ed.) <i>State of The Art: AIDS and Economics</i> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>), IAEN, 49-55.</cite></li>
<li id="_note-Bollinger"><b><a  title="">^</a></b> Bollinger, L. and Stover, J. (1999). <a  class="external text" title="http://www.iaen.org/impact/stovboll.pdf">The Economic Impact of AIDS</a> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). iaen. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_28.html" title="March 28">03-28</a>.</li>
<li id="_note-WBank"><b><a  title="">^</a></b> <cite style="font-style:normal">Over, M. (1992). "The macroeconomic impact of AIDS in Sub-Saharan Africa, Population and Human Resources Department". <i>The World Bank</i>.</cite></li>
<li id="_note-Bonnel"><b><a  title="">^</a></b> <cite style="font-style:normal">Bonnel, R. (2000). "HIV/AIDS and Economic Growth: A Global Perspective". <i>S. A. J. Economics</i> <b>68</b> (5): 820-855.</cite></li>
<li id="_note-eldis"><b><a  title="">^</a></b> Bell, C., Gersbach, H. and Devarajan, S. (2003). <a  class="external text" title="http://www.eldis.org/static/DOC12805.htm">The long-run economic costs of AIDS: theory and an application to South Africa</a>. eldis. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_28.html" title="March 28">03-28</a>.</li>
<li id="_note-UNAIDS2006Ch4"><b><a  title="">^</a></b> <cite class="book" style="font-style:normal"><a href="/wiki/UNAIDS.html" title="UNAIDS">UNAIDS</a> (2006). “<a  class="external text" title="http://data.unaids.org/pub/GlobalReport/2006/2006_GR_CH04_en.pdf">The impact of AIDS on people and societies</a>”, <i>2006 Report on the global AIDS epidemic</i> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_14.html" title="June 14">06-14</a>.</cite></li>
<li id="_note-Herek1999">^ <a  title=""><sup><i><b>a</b></i></sup></a>&#160;<a  title=""><sup><i><b>b</b></i></sup></a>&#160;<a  title=""><sup><i><b>c</b></i></sup></a> Herek, G. M. and Capitanio, J. P. (1999). <a  class="external text" title="http://psychology.ucdavis.edu/rainbow/html/abs99_sp.pdf">AIDS Stigma and sexual prejudice</a> (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). Am. Behav, Scientist. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_27.html" title="March 27">03-27</a>.</li>
<li id="_note-Snyder"><b><a  title="">^</a></b> <cite style="font-style:normal">Snyder M, Omoto AM, Crain AL. (1999). "Punished for their good deeds: stigmatization for AIDS volunteers". <i>American Behavioral Scientist</i> <b>42</b> (7): 1175-1192.</cite></li>
<li id="_note-Herek"><b><a  title="">^</a></b> <cite style="font-style:normal">Herek GM, Capitanio JP, Widaman KF. (2002). "<a  class="external text" title="http://psychology.ucdavis.edu/rainbow/html/ajph2002.pdf">HIV-related stigma and knowledge in the United States: prevalence and trends, 1991-1999</a>" (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). <i>Am. J. Public Health.</i> <b>92</b> (3): 371-377.</cite></li>
<li id="_note-HRSA"><b><a  title="">^</a></b> United States Health Resources and Services Administration. <a  class="external text" title="http://hab.hrsa.gov/publications/stigma/front.htm">Stigma and HIV-AIDS, A review of the literature</a>. HRSA. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/March_24.html" title="March 24">03-24</a>.</li>
<li id="_note-MMWR2"><b><a  title="">^</a></b> <a href="/wiki/CDC.html" title="CDC">CDC</a> (1981). <a  class="external text" title="http://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm">Pneumocystis Pneumonia --- Los Angeles</a>. CDC. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/January_17.html" title="January 17">01-17</a>.</li>
<li id="_note-Zhu"><b><a  title="">^</a></b> <cite style="font-style:normal">Zhu, T., Korber, B. T., Nahmias, A. J., Hooper, E., Sharp, P. M. and Ho, D. D. (1998). "An African HIV-1 Sequence from 1959 and Implications for the Origin of the Epidemic". <i>Nature</i> <b>391</b> (6667): 594-597. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9468138&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a> <a href="/wiki/Digital_object_identifier.html" title="Digital object identifier">DOI</a>:<a  class="external text" title="http://dx.doi.org/10.1038/35400">10.1038/35400</a>.</cite></li>
<li id="_note-Kolata"><b><a  title="">^</a></b> Kolata, G..&#160;"<a  class="external text" title="http://query.nytimes.com/gst/fullpage.html?res=9B0DEFD6173AF93BA15753C1A961948260&amp;sec=&amp;pagewanted=all">Boy's 1969 death suggests AIDS invaded U.S. several times</a>", <i>The New York Times</i>, <a href="/wiki/1987.html" title="1987">1987</a>-<a href="/wiki/October_28.html" title="October 28">10-28</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_19.html" title="June 19">06-19</a>.</li>
<li id="_note-HooperBMJ"><b><a  title="">^</a></b> <cite style="font-style:normal">Hooper, E. (1997). "<a  class="external text" title="http://bmj.bmjjournals.com/cgi/content/full/315/7123/1689">Sailors and star-bursts, and the arrival of HIV</a>". <i>BMJ</i> <b>315</b> (7123): 1689-1691. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=9448543&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Reeves"><b><a  title="">^</a></b> <cite style="font-style:normal">Reeves, J. D. and Doms, R. W (2002). "Human Immunodeficiency Virus Type 2". <i>J. Gen. Virol.</i> <b>83</b> (Pt 6): 1253-1265. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=12029140&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Keele"><b><a  title="">^</a></b> <cite style="font-style:normal">Keele, B. F., van Heuverswyn, F., Li, Y. Y., Bailes, E., Takehisa, J., Santiago, M. L., Bibollet-Ruche, F., Chen, Y., Wain, L. V., Liegois, F., Loul, S., Mpoudi Ngole, E., Bienvenue, Y., Delaporte, E., Brookfield, J. F. Y., Sharp, P. M., Shaw, G. M., Peeters, M., Hahn, B. H. (2006). "<a  class="external text" title="http://www.sciencemag.org/cgi/content/abstract/1126531">Chimpanzee Reservoirs of Pandemic and Nonpandemic HIV-1</a>". <i>Science</i> <b>Online <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/May_25.html" title="May 25">05-25</a></b>. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=16728595&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a><a href="/wiki/Digital_object_identifier.html" title="Digital object identifier">DOI</a>:<a  class="external text" title="http://dx.doi.org/10.1126/science.1126531">10.1126/science.1126531</a>.</cite></li>
<li id="_note-Curtis"><b><a  title="">^</a></b> <cite style="font-style:normal">Curtis, T. (1992). "<a  class="external text" title="http://www.uow.edu.au/arts/sts/bmartin/dissent/documents/AIDS/Curtis92.html">The origin of AIDS</a>". <i>Rolling Stone</i> (626): 54-59, 61, 106, 108.</cite></li>
<li id="_note-Hooper"><b><a  title="">^</a></b> <cite class="book" style="font-style:normal">Hooper, E. (1999). <i>The River&#160;: A Journey to the Source of HIV and AIDS</i>, 1st, Boston, MA: Little Brown &amp; Co, 1-1070. <a  class="internal">ISBN 0-316-37261-7</a>.</cite></li>
<li id="_note-Berry"><b><a  title="">^</a></b> <cite style="font-style:normal">Berry N, Jenkins A, Martin J, Davis C, Wood D, Schild G, Bottiger M, Holmes H, Minor P, Almond N (2005). "Mitochondrial DNA and retroviral RNA analyses of archival oral polio vaccine (OPV CHAT) materials: evidence of macaque nuclear sequences confirms substrate identity.". <i>Vaccine</i> <b>23</b>: 1639-1648. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15705467&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Duesberg"><b><a  title="">^</a></b> <cite style="font-style:normal">Duesberg, P. H. (1988). "HIV is not the cause of AIDS". <i>Science</i> <b>241</b> (4865): 514, 517. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=3399880&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Papadopulos"><b><a  title="">^</a></b> <cite style="font-style:normal">Papadopulos-Eleopulos, E., Turner, V. F., Papadimitriou, J., Page, B., Causer, D., Alfonso, H., Mhlongo, S., Miller, T., Maniotis, A. and Fiala, C. (2004). "A critique of the Montagnier evidence for the HIV/AIDS hypothesis". <i>Med Hypotheses</i> <b>63</b> (4): 597-601. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15325002&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Cohen"><b><a  title="">^</a></b> <cite style="font-style:normal">Cohen, J. (1994). "<a  class="external text" title="http://www.sciencemag.org/feature/data/cohen/266-5191-1642a.pdf">The Duesberg phenomenon</a>" (<small><a href="/wiki/Portable_Document_Format.html" title="Portable Document Format">PDF</a></small>). <i>Science</i> <b>266</b> (5191): 1642-1644. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=7992043&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a>.</cite></li>
<li id="_note-Kaiser"><b><a  title="">^</a></b> Various (<a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/August_13.html" title="August 13">08-13</a>). <a  class="external text" title="http://www.virusmyth.net/aids/controversy.htm">HIV Science and Responsible Journalism. Seminar at the XVI International AIDS Conference</a>. <a href="/wiki/Kaiser_Family_Foundation.html" title="Kaiser Family Foundation">Kaiser Family Foundation</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_19.html" title="June 19">06-19</a>.</li>
<li id="_note-controversy"><b><a  title="">^</a></b> Various. <a  class="external text" title="http://www.virusmyth.net/aids/controversy.htm">Controversy</a>. <a  class="new" title="Virusmyth.com">virusmyth.com</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_19.html" title="June 19">06-19</a>.</li>
<li id="_note-Cohenseries"><b><a  title="">^</a></b> <cite style="font-style:normal">Cohen, J. (1994). "<a  class="external text" title="http://www.sciencemag.org/feature/data/cohen/266-5191-1642a.pdf">The Controversy over HIV and AIDS</a>". <i>Science</i> <b>266</b> (5191): 1642-1649.</cite></li>
<li id="_note-NIAIDlink"><b><a  title="">^</a></b> Various. <a  class="external text" title="http://www3.niaid.nih.gov/news/focuson/hiv/resources/">Focus on the HIV-AIDS Connection: Resource links</a>. <a href="/wiki/National_Institute_of_Allergy_and_Infectious_Diseases.html" title="National Institute of Allergy and Infectious Diseases">National Institute of Allergy and Infectious Diseases</a>. Retrieved on <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/September_7.html" title="September 7">09-07</a>.</li>
<li id="_note-Glauser"><b><a  title="">^</a></b> <cite style="font-style:normal">Glauser, M. P., Francioli, P. (1984). "Clinical and epidemiological survey of acquired immune deficiency syndrome in Europe". <i>Eur. J. Clin. Microbiol.</i> <b>3</b> (1): 55-58. <a  class="external text" title="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=6705776&amp;query_hl=14&amp;itool=pubmed_docsum">PubMed</a> <a href="/wiki/Digital_object_identifier.html" title="Digital object identifier">DOI</a>:<a  class="external text" title="http://dx.doi.org/10.1007/BF02032823">10.1007/BF02032823</a>.</cite></li>
</ol>
</div>
<div id="section_SpokenWikipedia" class="infobox sisterproject noprint">
<div style="text-align: center"><b><a  class="internal" title="AIDS.ogg">Listen to this article</a> · <a  title="Image:AIDS.ogg">(info)</a></b></div>
<div style="float: left; margin-left: 5px;">
<div class="floatnone"><span><a  class="image" title="Spoken Wikipedia"><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/47/Sound-icon.svg/45px-Sound-icon.svg.png" alt="Spoken Wikipedia" width="45" height="34" longdesc="/wiki/Image:Sound-icon.svg" /></a></span></div>
</div>
<div style="font-size: xx-small; line-height: 1.6em; margin-left: 60px;">This audio file was created from an article revision dated <a href="/wiki/2006.html" title="2006">2006</a>-<a href="/wiki/June_12.html" title="June 12">06-12</a>, and does not reflect subsequent edits to the article. (<a  title="Wikipedia:Media help">Audio help</a>)</div>
<div style="text-align: center; clear: both"><b><a  title="Wikipedia:Spoken articles">More spoken articles</a></b></div>
</div>
<div style="right:30px; display:none;" class="metadata topicon" id="spoken-icon">
<div style="position:relative; width:16px; height:12px; overflow:hidden;">
<div style="position:absolute; font-size:12px; overflow:hidden; line-height:12px; letter-spacing:16px;"><a  class="internal" title="AIDS.ogg"><span title="This is a spoken article. Click here to listen." style="text-decoration:none;">&#160; &#160;</span></a></div>
<a  class="image" title="This is a spoken article. Click here to listen."><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/4/47/Sound-icon.svg/16px-Sound-icon.svg.png" alt="This is a spoken article. Click here to listen." width="16" height="12" longdesc="/wiki/Image:Sound-icon.svg" /></a></div>
</div>
<div style="clear:both;" class="NavFrame">
<div class="NavHead" style="background-color:#FFDEAD;">
<div style="float:left;margin-left:2px;">
<div class="noprint plainlinksneverexpand" id="Tnavbar" style="background-color: transparent; padding: 0; font-size:xx-small; color:#000000; white-space: nowrap;">This box:&#160;<a  class="external text" title="http://en.wikipedia.org/wiki/Template:AIDS"><span style="color:#002bb8;" title="View this template.">v</span></a>·<a  class="external text" title="http://en.wikipedia.org/wiki/Template_talk:AIDS"><span style="color:#002bb8;" title="Discussion about this template.">d</span></a>·<a  class="external text" title="http://en.wikipedia.org/w/index.php?title=Template:AIDS&amp;action=edit"><span style="color:#002bb8;" title="You can edit this template. Please use the preview button before saving.">e</span></a></div>
</div>
HIV/AIDS related topics</div>
<div class="NavContent" style="font-size:90%; padding:2px;">
<table style="background:none;">
<tr>
<td align="left" style="vertical-align: top;" width="90"><b>HIV</b></td>
<td align="left"><a href="/wiki/HIV.html" title="HIV">HIV</a>&#160;• <strong class="selflink">AIDS</strong>&#160;• <a href="/wiki/HIV_structure_and_genome.html" title="HIV structure and genome">HIV structure and genome</a>&#160;• <a href="/wiki/HIV_test.html" title="HIV test">HIV test</a>&#160;• <a href="/wiki/CDC_Classification_System_for_HIV_Infection.html" title="CDC Classification System for HIV Infection">CDC Classification System for HIV Infection</a>&#160;• <a href="/wiki/HIV_Disease_Progression_Rates.html" title="HIV Disease Progression Rates">HIV Disease Progression Rates</a>&#160;• <a href="/wiki/HIV_vaccine.html" title="HIV vaccine">HIV vaccine</a>&#160;• <a href="/wiki/WHO_Disease_Staging_System_for_HIV_Infection_and_Disease.html" title="WHO Disease Staging System for HIV Infection and Disease">WHO Disease Staging System for HIV Infection and Disease</a>&#160;• <a href="/wiki/AIDS_dementia_complex.html" title="AIDS dementia complex">AIDS dementia complex</a>&#160;• <a href="/wiki/Antiretroviral_drug.html" title="Antiretroviral drug">Antiretroviral drug</a></td>
</tr>
<tr>
<td align="left" style="vertical-align: top;" width="90"><b>History</b></td>
<td align="left"><a href="/wiki/AIDS_origin.html" title="AIDS origin">AIDS origin</a>&#160;• <a href="/wiki/AIDS_pandemic.html" title="AIDS pandemic">AIDS pandemic</a>&#160;• <a href="/wiki/AIDS_Museum.html" title="AIDS Museum">AIDS Museum</a>&#160;• <a href="/wiki/Timeline_of_AIDS.html" title="Timeline of AIDS">Timeline of AIDS</a>&#160;• <a href="/wiki/OPV_AIDS_hypothesis.html" title="OPV AIDS hypothesis">Oral polio vaccine AIDS hypothesis</a>&#160;• <a href="/wiki/AIDS_reappraisal.html" title="AIDS reappraisal">Reappraisal&#160;of&#160;HIV-AIDS&#160;Hypothesis</a>&#160;• <a href="/wiki/Duesberg_hypothesis.html" title="Duesberg hypothesis">Duesberg hypothesis</a></td>
</tr>
<tr>
<td align="left" style="vertical-align: top;" width="90"><b>Culture</b></td>
<td align="left"><a href="/wiki/International_AIDS_Conference.html" title="International AIDS Conference">International AIDS Conference</a>&#160;• <a href="/wiki/International_AIDS_Society.html" title="International AIDS Society">International AIDS Society</a>&#160;• <a href="/wiki/World_AIDS_Day.html" title="World AIDS Day">World AIDS Day</a>&#160;• <a href="/wiki/Treatment_Action_Campaign.html" title="Treatment Action Campaign">Treatment Action Campaign</a>&#160;• <a href="/wiki/Joint_United_Nations_Programme_on_HIV/AIDS.html" title="Joint United Nations Programme on HIV/AIDS">UNAIDS</a>&#160;• <a href="/wiki/NAMES_Project_AIDS_Memorial_Quilt.html" title="NAMES Project AIDS Memorial Quilt">NAMES Project AIDS Memorial Quilt</a>&#160;• <a href="/wiki/Common_misconceptions_about_HIV_and_AIDS.html" title="Common misconceptions about HIV and AIDS">Common misconceptions about HIV and AIDS</a>&#160;• <a href="/wiki/List_of_HIV-positive_people.html" title="List of HIV-positive people">List of HIV-positive people</a>&#160;• <a href="/wiki/People_With_AIDS_Self-Empowerment_Movement.html" title="People With AIDS Self-Empowerment Movement">People With AIDS Self-Empowerment Movement</a>&#160;• <a  title="Category:HIV-positive fictional characters">HIV-positive fictional&#160;characters</a></td>
</tr>
<tr>
<td align="left" style="vertical-align: top;" width="90"><b>By region or country</b></td>
<td align="left">Articles on the <a href="/wiki/AIDS_pandemic.html" title="AIDS pandemic">AIDS pandemic</a> in... <a href="/wiki/HIV/AIDS_in_Africa.html" title="HIV/AIDS in Africa">Sub-Saharan Africa</a>&#160;• <a href="/wiki/HIV/AIDS_in_Asia.html" title="HIV/AIDS in Asia">Asia</a>&#160;• <a href="/wiki/HIV/AIDS_in_the_Caribbean.html" title="HIV/AIDS in the Caribbean">the Caribbean</a>&#160;• <a href="/wiki/HIV/AIDS_in_China.html" title="HIV/AIDS in China">China</a>&#160;• <a href="/wiki/HIV/AIDS_in_Eastern_Europe_and_Central_Asia.html" title="HIV/AIDS in Eastern Europe and Central Asia">Eastern&#160;Europe&#160;and&#160;Central&#160;Asia</a>&#160;• <a href="/wiki/HIV/AIDS_in_Western_Europe.html" title="HIV/AIDS in Western Europe">Western&#160;Europe</a>&#160;• <a href="/wiki/HIV/AIDS_in_India.html" title="HIV/AIDS in India">India</a>&#160;• <a href="/wiki/HIV/AIDS_in_Latin_America.html" title="HIV/AIDS in Latin America">Latin&#160;America</a>&#160;• <a  class="new" title="HIV/AIDS in Russia">Russia</a>&#160;• <a href="/wiki/HIV/AIDS_in_the_United_States.html" title="HIV/AIDS in the United States">United&#160;States</a>&#160;• <a href="/wiki/HIV/AIDS_in_Taiwan.html" title="HIV/AIDS in Taiwan">Taiwan</a>&#160;• <a href="/wiki/List_of_countries_by_HIV/AIDS_adult_prevalence_rate.html" title="List of countries by HIV/AIDS adult prevalence rate">List of countries by HIV/AIDS adult prevalence rate</a></td>
</tr>
</table>
</div>
</div>
<div class="editsection" style="float:right;margin-left:5px;">[<a  title="Edit section: External links">edit</a>]</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><font color="#FFFFFF">External links</font></h2>
<div style="clear: both; width: 100%; padding: 0; text-align: left; border: none;" class="NavFrame">
<div style="background: #ccddcc; text-align: center; border: 1px solid #667766" class="NavHead"><b>External links</b></div>
<div class="NavContent">
<div class="infobox sisterproject">
<div class="floatleft"><span><a  class="image" title=" "><img src="http://upload.wikimedia.org/wikipedia/commons/thumb/8/8a/Wikinews-logo.png/45px-Wikinews-logo.png" alt=" " width="45" height="23" longdesc="/wiki/Image:Wikinews-logo.png" /></a></span></div>
<div style="margin-left: 60px;"><a href="/wiki/Wikinews.html" title="Wikinews">Wikinews</a> has news related to:
<div style="margin-left: 10px;"><i><b><a  class="extiw" title="wikinews:UN/WHO_making_progress_in_treating_HIV/AIDS,_but_will_miss_2005_target">UN/WHO making progress in treating HIV/AIDS, but will miss 2005 target</a></b></i></div>
</div>
</div>
<dl>
<dt>HIV/AIDS resources</dt>
</dl>
<ul>
<li><a  class="external text" title="http://www.medscape.com/hiv">MEDSCAPE.com</a> An huge and extensive site dedicated to everything medical related with an impressive HIV/AIDS section.</li>
<li><a  class="external text" title="http://www.AIDSeducator.org/">AIDS Educator</a>: Nonprofit making effective AIDS education programs and essential resources widely available to anyone in a position to teach others about HIV/AIDS</li>
<li><a  class="external text" title="http://www.POZ.com">POZ.com</a> Comprehensive resource for the HIV/AIDS community, including all 12 years of POZ Magazine archives.</li>
<li><a  class="external text" title="http://www.aegis.org/">AEGiS.org</a> AIDS Education Global Information System</li>
<li><a  class="external text" title="http://www.avert.org/">AVERT AIDS Education &amp; Research Trust from the U.K</a></li>
<li><a  class="external text" title="http://www.HIVMedicine.com">HIV Medicine 2005</a> Free medical textbook updated annually.</li>
<li><a  class="external text" title="http://www.eldis.org/hivaids/">Eldis HIV and AIDS</a> - latest research and other resources on HIV and AIDS in developing countries</li>
<li><a  class="external text" title="http://www.aids.org/">AIDS.ORG</a>: Comprehensive HIV/AIDS Information</li>
<li><a  class="external text" title="http://aidsinfo.nih.gov/Glossary/GlossaryDefaultCenterPage.aspx?MenuItem=AIDSinfoTools">HIV/AIDS glossary from the U. S. Department of Health and Human Services</a></li>
<li><a  class="external text" title="http://www.aidsmeds.com">AIDSmeds.com</a>: Comprehensive lessons on HIV/AIDS and their treatments</li>
<li><a  class="external text" title="http://www.thebody.com/index.shtml">The Body: The Complete HIV/AIDS Resource</a></li>
<li><a  class="external text" title="http://www.niaid.nih.gov/publications/aids.htm">AIDS facts and news from the National Institute of Allergy and Infectious Diseases</a></li>
<li><a  class="external text" title="http://www.newscientist.com/channel/health/hiv">HIV and AIDS from New Scientist</a></li>
<li><a  class="external text" title="http://www.aidsnews.org/">AIDS treatment news</a></li>
<li><a  class="external text" title="http://www.aidsarchive.com">AIDS Newspaper Articles Archive</a></li>
<li><a  class="external text" title="http://www.ifara.tv/">Interviews from the 2006 Conference on Retrovirus' produced by IFARA.TV</a></li>
<li><a  class="external text" title="http://www.bethegeneration.org">Be the Generation</a> - Information on HIV Vaccine Clinical Research in 20 American Cities]</li>
<li><a  class="external text" title="http://www.cdc.gov/nchstp/od/nchstp.html">The National Center for HIV, STD, and TB Prevention</a> - A Division of the <a href="/wiki/Centers_for_Disease_Control_and_Prevention.html" title="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</a></li>
<li><a  class="external text" title="http://www.histopathology-india.net/AIDS.htm">Cutaneous Lesions related to AIDS</a></li>
<li><a  class="external text" title="http://www.acria.org">AIDS Community Research Initiative of America</a> - Community-based research and education for people living with HIV.</li>
</ul>
<dl>
<dt>HIV/AIDS associations and programs</dt>
</dl>
<ul>
<li><a  class="external text" title="http://www.unaids.org/en/default.asp">The Joint United Nations Programme on HIV/AIDS (UNAIDS)</a></li>
<li><a  class="external text" title="http://www.iasociety.org/">International AIDS Society</a> - the world's leading independent association of HIV/AIDS professionals</li>
<li><a  class="external text" title="http://www.worldbank.org/oed/aids">Evaluating the World Bank's Assistance for Fighting the HIV/AIDS Epidemic</a></li>
<li><a  class="external text" title="http://www.phrusa.org/campaigns/aids/who_031303.html">Health Action: HIV Transmission in the Medical Setting</a></li>
<li><a  class="external text" title="http://www.theglobalfund.org/en/about/aids/">The Global Fund to fight AIDS, Tuberculosis and Malaria</a> (<a href="/wiki/The_Global_Fund_to_Fight_AIDS%2C_Tuberculosis_%26_Malaria.html" title="The Global Fund to Fight AIDS, Tuberculosis &amp; Malaria">Wikipedia Article</a>)</li>
<li><a  class="external text" title="http://www.iasstdaids.org">IASSTD &amp; AIDS</a> - Indian Association for the Study of Sexually Transmitted Diseases &amp; AIDS</li>
<li><a  class="external text" title="http://www.nacptz.org/">National AIDS Control Programme (NACP), Tanzania</a></li>
</ul>
<dl>
<dt>Support groups and activism</dt>
</dl>
<ul>
<li><a  class="external text" title="http://www.globalgiving.com/index.html?RF=wikipedia_hivaids/">Global Giving</a> - provides funding for global HIV/AIDS projects</li>
<li><a  class="external text" title="http://www.pedaids.org/">Elizabeth Glaser Pediatric AIDS Foundation</a></li>
<li><a  class="external text" title="http://www.worldaidsday.org/">World AIDS Day</a> World AIDS Day <a href="/wiki/December_1.html" title="December 1">1 December</a></li>
<li><a  class="external text" title="http://www.worldcommunitygrid.org/">World Community Grid</a> - A community supported by Sun Microsystems and IBM. Website has downloadable program which, among other things, uses your PC's spare processing power to analyze how effective a HIV treatment will be.</li>
<li><a  class="external text" title="http://www.fightglobalaids.org/">Student global AIDS campaign</a></li>
<li><a  class="external text" title="http://www.ejaf.org/">Elton John AIDS Foundation</a></li>
<li><a  class="external text" title="http://www.acet-international.org/">AIDS Care Education and Training</a> (<a href="/wiki/ACET.html" title="ACET">Wikipedia Article</a>)</li>
<li><a  class="external text" title="http://www.mercuryphoenixtrust.com/">Mercury Phoenix Trust</a></li>
<li><a  class="external text" title="http://www.teenaids.org/">TeenAIDS-PeerCorps</a> - focuses on spreading HIV/AIDS education to teenagers around the world</li>
<li><a  class="external text" title="http://www.sfaf.org/">San Francisco AIDS Foundation</a></li>
</ul>
<dl>
<dt>Documentaries &amp; Reports</dt>
</dl>
<ul>
<li><i><a href="/wiki/Frontline_%28TV_series%29.html" title="Frontline (TV series)">FRONTLINE</a>: <a  class="external text" title="http://www.pbs.org/wgbh/pages/frontline/aids/">The Age of AIDS</a></i> Twenty-five years after the first cases of AIDS were diagnosed, this program chronicles the scientific, political and social history of the epidemic.</li>
<li>Documentation on the oral polio vaccine (OPV) theory of AIDS origin <a  class="external text" title="http://www.aidsorigins.com/">AIDSOrigin.com</a></li>
<li>Documentary about AIDS in Africa: <a  class="external text" title="http://www.insightnewstv.com/aids">Living with AIDS</a></li>
<li>Origin of Aids Video <a  class="external text" title="http://www.documentary-film.net/search/video-listings.php?e=5">Watch Free online&#160;: Origin of Aids Video</a></li>
<li>Recorded interview with Prof. Robert Gallo about <a  class="external text" title="http://www.isracast.com/transcripts/011205a_trans.htm">the progress in HIV vaccine research</a></li>
<li><a  class="external text" title="http://economist.com/agenda/displaystory.cfm?story_id=E1_GJJSVGD">The Economist&#160;: 25 Years - Taking on the epidemic</a> ( Subscription required )</li>
<li><a  class="external text" title="http://archives.cbc.ca/IDD-1-70-413/disasters_tragedies/early_aids/">CBC Digital Archives - The Early Years of the AIDS Crisis</a></li>
<li><a  class="external text" title="http://www.documen.tv/asset/The_Gift.html">Documentary "THE GIFT" The Phenomenon of deliberate HIV infection</a></li>
<li><a  class="external text" title="http://www.time.com/time/magazine/article/0,9171,1223367,00.html">"The Graying of AIDS" Older Americans Living with HIV Face Unique Challenges</a> <i>TIME</i> magazine, August 14, 2006</li>
</ul>
<table class="toccolours" style="width: 100%; border-top: none;">
<tr>
<td></td>
</tr>
</table>
</div>
</div>
<div style="right:10px; display:none;" class="metadata topicon" id="featured-star">
<div style="position: relative; width: 14px; height: 14px; overflow: hidden">
<div style="position: absolute; top: 0px; left: 0px; font-size: 100px; overflow: hidden; line-height: 100px; z-index: 3"><a  title="Wikipedia:Featured articles"><span title="This is a featured article. Click here for more information.">&#160;&#160;&#160;</span></a></div>
<div style="position: absolute; top: 0px; left: 0px; z-index: 2"><a  class="image" title="This is a featured article. Click here for more information."><img src="http://upload.wikimedia.org/wikipedia/en/6/60/LinkFA-star.png" alt="This is a featured article. Click here for more information." width="14" height="14" longdesc="/wiki/Image:LinkFA-star.png" /></a></div>
</div>
</div>
<p><span class="FA" id="he" style="display:none;"></span> <span class="FA" id="vi" style="display:none;"></span></p>

<!-- 
Pre-expand include size: 373840 bytes
Post-expand include size: 159577 bytes
Template argument size: 131933 bytes
Maximum: 2048000 bytes
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:5069516-0!1!0!default!!en!2 and timestamp 20060910161121 -->
<div class="printfooter">
Retrieved from "<a </div>
			<div id="catlinks"><p class='catlinks'><a  title="Special:Categories">Categories</a>: <span dir='ltr'><a  title="Category:Articles with unsourced statements">Articles with unsourced statements</a></span> | <span dir='ltr'><a  title="Category:Spoken articles">Spoken articles</a></span> | <span dir='ltr'><a  title="Category:HIV/AIDS">HIV/AIDS</a></span> | <span dir='ltr'><a  title="Category:Immune system disorders">Immune system disorders</a></span> | <span dir='ltr'><a  title="Category:Infectious diseases">Infectious diseases</a></span> | <span dir='ltr'><a  title="Category:Pandemics">Pandemics</a></span> | <span dir='ltr'><a  title="Category:Sexually-transmitted diseases">Sexually-transmitted diseases</a></span> | <span dir='ltr'><a  title="Category:Syndromes">Syndromes</a></span> | <span dir='ltr'><a  title="Category:Virology">Virology</a></span> | <span dir='ltr'><a  title="Category:AIDS origin hypotheses">AIDS origin hypotheses</a></span></p></div>			<!-- end content -->
			<div class="visualClear"></div>
		</div>
	</div>
		</div>
		<div id="column-one">
	<div id="p-cactions" class="portlet">
		<h5>Views</h5>
		<ul>
				 <li id="ca-nstab-main" class="selected"><a href="/wiki/AIDS.html">Article</a></li>
				 <li id="ca-talk"><a >Discussion</a></li>
				 <li id="ca-edit"><a >Edit this page</a></li>
				 <li id="ca-history"><a >History</a></li>
		</ul>
	</div>
	<div class="portlet" id="p-personal">
		<h5>Personal tools</h5>
		<div class="pBody">
			<ul>
				<li id="pt-login"><a >Sign in / create account</a></li>
			</ul>
		</div>
	</div>
	<div class="portlet" id="p-logo">
		<a style="background-image: url(/images/wiki-en.png);" href="/wiki/Main_Page.html" title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
		<h5>Navigation</h5>
		<div class='pBody'>
			<ul>
				<li id="n-mainpage"><a href="/wiki/Main_Page.html">Main Page</a></li>
				<li id="n-portal"><a >Community Portal</a></li>
				<li id="n-Featured-articles"><a >Featured articles</a></li>
				<li id="n-currentevents"><a >Current events</a></li>
				<li id="n-recentchanges"><a >Recent changes</a></li>
				<li id="n-randompage"><a >Random article</a></li>
				<li id="n-help"><a >Help</a></li>
				<li id="n-contact"><a >Contact Wikipedia</a></li>
				<li id="n-sitesupport"><a >Donations</a></li>
			</ul>
		</div>
	</div>
		<div id="p-search" class="portlet">
		<h5><label for="searchInput">Search</label></h5>
		<div id="searchBody" class="pBody">
			<form action="/wiki/Special:Search" id="searchform"><div>
				<input id="searchInput" name="search" type="text" accesskey="f" value="" />
				<input type='submit' name="go" class="searchButton" id="searchGoButton"	value="Go" />&nbsp;
				<input type='submit' name="fulltext" class="searchButton" value="Search" />
			</div></form>
		</div>
	</div>
	<div class="portlet" id="p-tb">
		<h5>Toolbox</h5>
		<div class="pBody">
			<ul>
				<li id="t-whatlinkshere"><a >What links here</a></li>
				<li id="t-recentchangeslinked"><a >Related changes</a></li>
<li id="t-upload"><a >Upload file</a></li>
<li id="t-specialpages"><a >Special pages</a></li>
				<li id="t-print"><a >Printable version</a></li>				<li id="t-permalink"><a >Permanent link</a></li><li id="t-cite"><a >Cite this article</a></li>			</ul>
		</div>
	</div>
	<div id="p-lang" class="portlet">
		<h5>In other languages</h5>
		<div class="pBody">
			<ul>
				<li class="interwiki-af"><a >Afrikaans</a></li>
				<li class="interwiki-als"><a >Alemannisch</a></li>
				<li class="interwiki-ar"><a >العربية</a></li>
				<li class="interwiki-bg"><a >Български</a></li>
				<li class="interwiki-bm"><a >Bamanankan</a></li>
				<li class="interwiki-bn"><a >বাংলা</a></li>
				<li class="interwiki-be"><a >Беларуская</a></li>
				<li class="interwiki-bs"><a >Bosanski</a></li>
				<li class="interwiki-ca"><a >Català</a></li>
				<li class="interwiki-cs"><a >Česky</a></li>
				<li class="interwiki-da"><a >Dansk</a></li>
				<li class="interwiki-de"><a >Deutsch</a></li>
				<li class="interwiki-es"><a >Español</a></li>
				<li class="interwiki-eo"><a >Esperanto</a></li>
				<li class="interwiki-et"><a >Eesti</a></li>
				<li class="interwiki-eu"><a >Euskara</a></li>
				<li class="interwiki-fa"><a >فارسی</a></li>
				<li class="interwiki-fr"><a >Français</a></li>
				<li class="interwiki-ga"><a >Gaeilge</a></li>
				<li class="interwiki-gd"><a >Gàidhlig</a></li>
				<li class="interwiki-ko"><a >한국어</a></li>
				<li class="interwiki-hi"><a >हिन्दी</a></li>
				<li class="interwiki-hr"><a >Hrvatski</a></li>
				<li class="interwiki-he"><a >עברית</a></li>
				<li class="interwiki-id"><a >Bahasa Indonesia</a></li>
				<li class="interwiki-is"><a >Íslenska</a></li>
				<li class="interwiki-it"><a >Italiano</a></li>
				<li class="interwiki-sw"><a >Kiswahili</a></li>
				<li class="interwiki-ku"><a >Kurdî / كوردي</a></li>
				<li class="interwiki-lv"><a >Latviešu</a></li>
				<li class="interwiki-lt"><a >Lietuvių</a></li>
				<li class="interwiki-ln"><a >Lingala</a></li>
				<li class="interwiki-hu"><a >Magyar</a></li>
				<li class="interwiki-mk"><a >Македонски</a></li>
				<li class="interwiki-ms"><a >Bahasa Melayu</a></li>
				<li class="interwiki-nl"><a >Nederlands</a></li>
				<li class="interwiki-ja"><a >日本語</a></li>
				<li class="interwiki-kn"><a >ಕನ್ನಡ</a></li>
				<li class="interwiki-no"><a >Norsk (bokmål)</a></li>
				<li class="interwiki-nn"><a >Norsk (nynorsk)</a></li>
				<li class="interwiki-pl"><a >Polski</a></li>
				<li class="interwiki-ps"><a >پښتو</a></li>
				<li class="interwiki-pt"><a >Português</a></li>
				<li class="interwiki-qu"><a >Runa Simi</a></li>
				<li class="interwiki-ru"><a >Русский</a></li>
				<li class="interwiki-scn"><a >Sicilianu</a></li>
				<li class="interwiki-simple"><a >Simple English</a></li>
				<li class="interwiki-sk"><a >Slovenčina</a></li>
				<li class="interwiki-sl"><a >Slovenščina</a></li>
				<li class="interwiki-sr"><a >Српски / Srpski</a></li>
				<li class="interwiki-fi"><a >Suomi</a></li>
				<li class="interwiki-sv"><a >Svenska</a></li>
				<li class="interwiki-ta"><a >தமிழ்</a></li>
				<li class="interwiki-tt"><a >Tatarça</a></li>
				<li class="interwiki-th"><a >ไทย</a></li>
				<li class="interwiki-vi"><a >Tiếng Việt</a></li>
				<li class="interwiki-tr"><a >Türkçe</a></li>
				<li class="interwiki-uk"><a >Українська</a></li>
				<li class="interwiki-zh"><a >中文</a></li>
				<li class="interwiki-zh-yue"><a >粵語</a></li>
			</ul>
		</div>
	</div>
		</div><!-- end of the left (by default at least) column -->
			<div class="visualClear"></div>
			<div id="footer">
				<div id="f-poweredbyico"><a ><img src="/skins-1.5/common/images/poweredby_mediawiki_88x31.png" alt="MediaWiki" /></a></div>
				<div id="f-copyrightico"><a ><img src="/images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>
			<ul id="f-list">
				<li id="lastmod"> This page was last modified 16:53, 8 September 2006.</li>
				<li id="copyright">All text is available under the terms of the <a class='internal'  title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal'  title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the Wikimedia Foundation, Inc.<br /></li>
				<li id="privacy"><a  title="wikimedia:Privacy policy">Privacy policy</a></li>
				<li id="about"><a  title="Wikipedia:About">About Wikipedia</a></li>
				<li id="disclaimer"><a  title="Wikipedia:General disclaimer">Disclaimers</a></li>
			</ul>
		</div>
		
	
		<script type="text/javascript">if (window.runOnloadHook) runOnloadHook();</script>
</div>
<!-- Served by srv72 in 0.080 secs. --></body></html>
